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Ultrasound is a type of mechanical energies that have been widely 
employed in clinical diagnosis and therapeutic use. The overall goal of this 
dissertation is to further develop ultrasound-based imaging modality in assisting 
cancer diagnosis and explore the transcranial focused ultrasound (tFUS) in brain 
stimulation. In this dissertation, I firstly summarize my research on detecting 
cancer by harnessing a passive-mode ultrasound generated by magnetoacoustics. 
Probing the electrical conductivity of in vivo tissues, a high-frequency 
magnetoacoustic tomography with magnetic induction (hfMAT-MI) imaging system 
has been developed for cancer imaging with 1-mm spatial resolution. With the aid 
of magnetic nanoparticles (MNPs), the magnetoacoustic tomography is further 
enhanced in the imaging contrast and thus used to reconstruct the in vivo 
biodistribution of MNPs noninvasively. By reversing the imaging model, I secondly 
introduce my studies of transmitting active-mode pulsed ultrasound in a 
transcranial way and electrically sensing global and local brain responses to the 
deposited low-intensity ultrasound energy. In this second research topic, non-
invasive electroencephalography (EEG)-based source imaging (ESI) is used to 
map the whole brain dynamics, which allows to better understand the effects of 
tFUS stimulation with high spatiotemporal resolutions. Furthermore, towards a 
mechanistic investigation, intracranial electrophysiological recordings from in vivo 
brains receiving low-intensity tFUS uncover an intrinsic cell-type specificity of 
neurons in responding to levels of ultrasound pulse repetition frequencies. 
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Potential confounding factors, i.e. auditory side effects and somatosensation are 
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Chapter 1: Introduction 
1.1 Magnetoacoustics: A Passive-mode Ultrasound Detection for Non-
Invasive Cancer Diagnosis 
1.1.1 Magnetoacoustic Tomography with Magnetic Induction (MAT-MI) for Probing 
Electrical Conductivity of Biological Tissues [1] 
Electrical properties of biological tissue including electrical 
conductivity σ and permittivity γ are important biophysical parameters in the study 
of electrophysiology and electromagnetic therapies such as transcranial direct 
current stimulation (tDCS) [2]. In addition, due to their changes under physiological 
and pathological conditions, tissue electrical properties may serve as an imaging 
contrast for possible diagnosis and research use [3]. Previous studies have shown 
that cancerous breast tumor tissue has significantly different electrical properties 
than normal breast tissue or benign tumors [4-6]. Significant electrical conductivity 
difference has also been found between liver tumors and normal liver tissue [7]. 
Generally, such differences between carcinoma and normal tissue are attributed 
to different cellular water content, amount of extracellular fluid, membrane 
permeability, packing density and orientation of the malignant cells [8]. Other than 
carcinomas, tissues under conditions of ischemia, hemorrhage or edema are 
expected to exhibit different electrical properties as blood and most body fluid have 
quite different conductivity and permittivity than most other soft tissues [9, 10]. 
Therefore, noninvasive imaging methods measuring tissue electrical properties 
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with good accuracy and high spatial resolution are of great research and clinical 
interest. 
Over decades, different electromagnetic imaging methods have been 
developed to measure electrical properties of biological tissue, including electrical 
impedance tomography (EIT) [11, 12], magnetic induction tomography (MIT) [13] 
and magnetic resonance electrical impedance tomography (MREIT) [14, 15]. 
Among these techniques, EIT maps tissue electrical properties using acquired 
surface voltage measurements in response to different current injections. Though 
EIT has advantages in its low cost, real-time speed and safety, major limitations 
including its low spatial resolution and degraded sensitivity in the center of an 
object still hinder its broader application. In addition, due to its use of current 
injection through surface electrodes, EIT may be limited by the 'shielding effect' 
[16] caused by an insulating or low conductive region in the object, such as bone 
or adipose tissue. In comparison, MIT uses dynamic magnetic field to induce 
current in conductive tissue and measures the second magnetic field generated by 
the induced eddy current using noncontact sensing coils. Yet, because of the ill-
posed inverse problem similar to EIT, the spatial resolution of current MIT 
techniques is still quite limited. In order to achieve high spatial resolution in imaging 
electrical conductivity, MREIT has been developed by combing EIT and magnetic 
resonance current density imaging (MRCDI) [17]. With current injection through 
surface electrodes similar to EIT while measuring the corresponding magnetic field 
disturbance generated by injected current in tissue through magnetic resonance 
imaging (MRI), MREIT made it possible to map electrical conductivity in ex 
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vivo and in vivo tissues with high spatial resolution [18, 19]. However, a relatively 
high level of current injection (on the level of mA) is generally required in MREIT 
to obtain sufficient signal-to-noise ratio (SNR) level and the use of MRI machines 
makes the cost of MREIT higher than other methods. 
Alternative approaches utilizing the coupling between electromagnetic field 
and acoustic field have also been developed to image electrical properties of tissue 
or bioelectrical current [20]. Such kind of coupling was first demonstrated in 
magnetoacoustic tomography (MAT) [21, 22] and Hall effect imaging (HEI) [23]. In 
MAT and HEI, the imaging object is placed in a static magnetic field. Spontaneous 
or injected current flow, which is associated with ion movement in biological tissue, 
is then coupled to acoustic vibrations through Lorentz force acting on these moving 
ions. Such vibrations can be sensitively detected by ultrasound transducers and 
used for possible mapping of the bioelectric current or tissue electrical properties 
with spatial resolution close to ultrasound imaging. Using similar coupling 
mechanism in a reverse mode, one can apply ultrasonic energy to the imaging 
object and record voltage/current signals to obtain the sample's conductivity 
information [24-26]. Such technique was also called magneto-acousto-electrical 
tomography (MAET) [27-29] or Lorentz force electrical impedance tomography 
(LFEIT) [30, 31]. Of course, the problem of the 'shielding effect' associated with 
the use of surface electrodes for current injection or voltage measurement, i.e. 
regions surrounded by low-conductive tissue become invisible, still exists in these 
methods. Such problems have then led to the development of magnetoacoustic 
tomography with magnetic induction (MAT-MI) [32, 33]. MAT-MI utilizes magnetic 
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induction to induce eddy current in the conductive sample and generates acoustic 
vibrations through the same Lorentz force coupling mechanism as in MAT or HEI. 
Ultrasound waves are then sensed to reconstruct the electrical conductivity related 
image. Ever since the MAT-MI method was proposed, there have been many 
numerical studies [34-37] and experimental studies using physical phantoms [38-
40] or biological tissues [41, 42] demonstrating the feasibility and performance of 
MAT-MI. Advancement on experimental system design [43, 44] and image 
reconstruction algorithms [44, 45] has also been achieved in recent years. In 
addition, similar to the reverse mode of HEI or MAET, i.e. applying ultrasound 
transmission and measuring the Lorentz force induced current or voltage for 
imaging electrical conductivity, the reverse mode of MAT-MI—named magneto-
acousto-electrical tomography with magnetic induction (MAET-MI)—has also been 
developed recently [46], which uses ultrasound stimulation and coil measurement 
of the dynamic magnetic field generated by Lorentz force induced current in 
conductive imaging objects. 
1.1.2 Magnetoacoustic Tomography (MAT) for Imaging Magnetic Iron Oxide 
Nanoparticles [47] 
In recent years, magnetic nanoparticles (MNPs) have been widely used as 
contrast agents in a variety of clinical and molecular imaging modalities [48]. 
Target specificity is typically accomplished by coating MNPs with appropriate 
tumor/tissue specific markers, such as antibodies, allowing them to bind to the 
tumor region [49, 50]. These nanoparticles can then be imaged within the tumors 
for clinical applications such as detection or pre-treatment planning. For instance, 
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there is a wide consensus that early detection of cancer improves both 5-year 
survival rates and quality of life for patients. As seen in clinical data from 24,740 
cases, five-year breast cancer survival rates can reach 96.2% if the tumor is 
diagnosed when the size is less than 5 mm [51]. This has led to significant effort 
in exploration of contrast agents and biomarker indicating tumors [52]. Also, 
techniques are being actively developed to image cancer through the use of 
indigenous tissue properties such as elastic properties [53] or electrical properties 
(EP) at various electromagnetic wavelengths [33, 54-58]. The goal of these efforts 
is to obtain highly sensitive, good resolution detection of tumors. 
In addition to magnetic nanoparticles being used as imaging contrast agents, 
they are also being actively investigated as therapeutic agents owing to the ability 
to heat MNPs by alternating radiofrequency (RF) magnetic fields. Thus, the use of 
magnetic nanoparticles could lead to theranostic (therapeutic and diagnostic) 
applications in cancer management [59-61]. For these reasons, developing high 
spatial resolution imaging techniques for the detection of the distribution of these 
MNPs in tissue is desired. 
Several imaging techniques for estimating the distribution of nanoparticles 
in tumors have been explored in recent years. Magnetic resonance imaging (MRI) 
was first used to image magnetic nanoparticle-labeled molecular targets, as it can 
provide an enhanced imaging contrast because of its nature and properties 
significantly shortening T2 relaxation time [62, 63].  The reduced relaxation time of 
the signal in MRI is seen to depend on the concentration of the magnetic 
nanoparticles used, and research is ongoing to be able to reliably detect these 
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nanoparticles under shortened relaxation times at nanoparticle concentration 
levels in the 1–10 mg Fe/ml range [64]. Using the sweep imaging with fourier 
transformation (SWIFT) MRI technique, quantitative imaging of up to 3 mg Fe/ml 
concentration of iron oxide nanoparticles (IONPs) is possible [64, 65]. CT scanning 
has also been explored as another approach for estimating the distribution of 
magnetic nanoparticles [66]. The IONP distribution above 10 mg Fe/ml is well 
recognized in the CT images with the sensitivity limited below this concentration 
[66].  In addition, the cost of MRI or CT imaging systems represents an economic 
burden for large scale screening for early cancer detection applications [67].  
Another approach that has been explored for detecting MNPs is based on the 
heating effect [61, 68] which applies alternating magnetic fields and raises the 
temperature of the MNP labeled tumor. This raises the temperature distribution 
around the tumor which is then used to estimate its location. However, this 
technique is limited by its ability to detect superficial tumors at depths of up to 1.5 
cm under the surface. It is also limited by the amount of heat applicable to the 
tissue for diagnostic purposes. On the other hand, ultrasound penetrates soft 
tissue with imaging depths of tens of centimeters in the current ultrasound systems 
in the few MHz frequency range [69]; in this frequency range, the imaging 
resolution is better than 1 mm. In addition, ultrasound based systems could provide 
a cost-effective imaging alternative to MRI or CT. 
Recently, several ultrasound-based imaging techniques have been 
developed in which a secondary effect of the nanoparticles is being used to 
indicate their presence. Photoacoustic (PA) imaging is based on the detection of 
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changes in optical absorption properties due to the presence of nanoparticles. In 
PA imaging, nano agents with well-characterized absorption spectrums absorb the 
applied laser pulses. This energy then converts to heat, generating acoustic waves 
detectable with an ultrasound receiver [70, 71]. In magneto-motive force based 
nanoparticle detection, an RF magnetic field is applied to the tissue labeled with 
MNPs experiencing a mechanical force from the magnetic field. The resultant 
mechanical fields from this force can then be used to image the nanoparticles 
present in the tissue, which is a diamagnetic medium without such magnetic forces. 
Imaging methods using these magneto-motive forces, leading to the displacement 
in MNP labeled tissue, have been proposed for reconstructing these nanoparticle 
distributions [72-75]. One such technique is based on displacement 
measurements using optical coherence tomography (OCT) called magneto-motive 
optical coherent tomography (MM-OCT) [72, 73]. However, MM-OCT has limited 
detection depth due to the strong scattering of light in tissues. Alternatively, 
ultrasound based methods using B-mode or M-mode ultrasound measurements of 
magnetic nanoparticle displacement for deep tissue imaging have been proposed 
as presented in magneto-motive ultrasound imaging (MM-US) [74, 75]. These 
previously used imaging methods using magneto-motive force either apply 
continuous alternating magnetic fields or millisecond long, alternating pulsed 
magnetic fields to generate tissue displacement images and perform 
measurement of the displacement which is prominently induced along the direction 
of the force. 
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In our new method called magneto acoustic tomography (MAT) [76],  we 
apply a short, microsecond duration magnetic pulse to the tissue with MNP. This 
leads to a short pulsed magneto motive force acting on the MNP creating acoustic 
vibrations that spread in all directions throughout the medium. In addition, these 
acoustic vibrations are at the same frequency as the dynamic magnetic field, which 
is chosen to match the ultrasound frequency range. This allows recording of these 
acoustic waves with ultrasound transducers placed around the object in this study. 
This measured signal can then be used to reconstruct the acoustic source 
distribution in the object by using possible ultrasound imaging approaches [77, 78] 
leading to the reconstructed images having a good resolution of ultrasound 
imaging and good imaging depth in soft tissue. The imaging resolution and depth 
are primarily governed by the ultrasound system used. The imaging resolution is 
a function of the ultrasound bandwidth and the imaging depth is governed by the 
ultrasound attenuation in tissue. In the MAT method the ultrasound transducer is 
used only in the sensing mode unlike traditional ultrasound imaging where the 
transducer acts as both transmitter and receiver of acoustic waves. This allows the 
MAT method to have improved imaging bandwidth, limited mainly by the receiving 
bandwidth of the transducer, leading to better resolution. Also, as compared to 
traditional ultrasound imaging, the MAT method has lower ultrasound attenuation 
due to the tissue from the reduced travel path of the acoustic waves from the MNPs 
embedded in tissue to the sensing transducer leading to improved imaging depth. 
The MAT method is similar to magneto acoustic tomography with magnetic 
induction (MAT-MI), which is being explored for high resolution bioimpedance 
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imaging [33, 79].  With MAT-MI a combination of pulsed and static magnetic fields 
is used to generate acoustic fields by using Lorentz force; this acoustic field can 
be used to estimate the high resolution conductivity distribution of the tissue. 
Different magnetic materials such as Fe, Ni, Mn, Co, Cr, and Gd in their 
metal, metal alloy or oxide forms can be used as magnetic contrast agents [80, 
81]. However, because metals and metal alloys are prone to oxidation and 
corrosion, stable metal oxides are widely used as MNP contrast agents. Toxicity 
considerations are also a factor in the choice of materials for a contrast agent. The 
presence of iron in human bodies and the low toxicity profile [82] have led to iron 
based nanoparticles being actively studied as contrast agents. Other materials that 
could be highly toxic require proper coating or chelation when used as contrast 
agent [81]. 
1.2 Ultrasound Neuromodulation: Actively Transmitting Transcranial 
Focused Ultrasound Wave for Non-Invasive Brain Stimulation 
1.2.1 Non-Invasive Imaging of Brain Networks Perturbed by Low-Intensity 
Transcranial Focused Ultrasound (tFUS) [83] 
Brain activity is distributed over the 3-D space and evolves in time. It is of 
great importance to be able to image noninvasively brain dynamics and 
connectomics with high spatial and temporal resolution [84, 85]. Perturbation-
based neuroimaging methods [85, 86] combining the light-based or 
electrical/electromagnetic neuromodulations with a variety of neuroimaging 
modalities, like electroencephalography (EEG), functional magnetic resonance 
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imaging (fMRI), and magnetoencephalography (MEG), are valuable tools for 
understanding the brain networks. Optogenetic neuromodulation, a light-based 
neuromodulation method, demonstrates excellent spatiotemporal specificity but 
requires an invasive implantation procedure [87]. Electrical/electromagnetic-based 
methods, such as the deep brain stimulation (DBS) [88, 89], vagus nerve 
stimulation (VNS) [90], electroconvulsive therapy [91], transcranial magnetic 
stimulation (TMS) [86, 92], transcranial direct current stimulation (tDCS) [93, 94], 
and transcranial alternating current stimulation (tACS) [95] have been pursued to 
modulate local neural circuits or treat various neurological and mental disorders. 
Compared to DBS and VNS, TMS and tDCS/tACS have the merit of being 
noninvasive, but have limited spatial resolution and focality. 
Recently, tFUS has been proposed for noninvasive neuromodulation due to 
its high spatial resolution [96-98]. In vivo experiments (in animals) have been 
reported using a range of ultrasonic parameters achieving either activation or 
suppression of neural activity. Yoo et al. [99] used a rabbit model to demonstrate 
that tFUS with a fundamental frequency of 690 kHz and spatial-peak temporal-
average intensity (Ispta) of 6.3 W/cm2 excites the exposed motor cortex, leading to 
behavioral manifests such as movement and detectable changes in the recorded 
electromyography (EMG) signals from subdermal electrodes inserted into forelimb 
muscle. Blood-oxygen level-dependent signals were already observed through 
fMRI studies using a lower ultrasound intensity (Ispta) of 1.6 W/cm2, whereas the 
acoustic stimulation with a spatial-peak pulse-average intensity (Isppa) of 6.4 W/cm2 
lasting for over 7–8 s renders a reduction in the magnitude of the P30 visual evoked 
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potential (VEP). Low-intensity tFUS (Ispta: 300 mW/cm2) was used by Yoo et al. 
[100] to sonicate the thalamus of anesthetized rats, and as indicated through 
physiological and behavioral changes, the rats’ recovery time was shortened 
significantly as measured by voluntary movement and pinch response. Using 
another low-intensity ultrasound stimulation experiment (Ispta: less than 13.5±3.8 
mW/cm2, fundamental frequency: 320 kHz), Deffieux et al. [101] administered 
tFUS to the left frontal eye field in two awake macaque rhesus monkeys, and found 
that tFUS delayed the ipsilateral mean antisaccade latencies compared to the non-
sonication case. Most recently, Lee et al. [102] targeted the 250-kHz tFUS at the 
primary sensorimotor cortex and visual cortex of anesthetized sheep, and recorded 
tFUS-evoked electrophysiological signals using a bilateral EMG and two-channel 
subdermal EEG system. It was found that the ultrasound intensity Isppa needed to 
be greater than 6 W/cm2 to elicit motor evoked potentials and sonication-triggered 
visual evoked potentials. Minor microhemorrhages in the primary visual cortex 
were reported which were due to the use of high intensity tFUS, indicating that the 
ultrasound parameters need to be considered carefully to ensure safe 
neuromodulatory effects. 
In the past years, several groups have applied ultrasound neuromodulation 
in humans. Hameroff et al. [103] harnessed a commercially available ultrasound 
machine working in standard B-mode to dose chronic pain subjects with 
transcranial ultrasound (Ispta: 152 mW/cm2 at transducer), and they reported that 
the subjects’ mood were improved for 10 min after the ultrasound mediation. Legon 
et al. [104] examined the effect of pulsed ultrasound stimulation on peripheral 
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somatosensory circuits by stimulating fingertips. Two ultrasound stimulation 
waveforms were designed to evoke either mechanical sensation (Ispta: 11.8 W/cm2) 
or thermal sensation (Ispta: 54.8 W/cm2), and the sonication effects on the neural 
circuits were indicated by both EEG and fMRI. Later, the group further examined 
the tFUS (Isppa: 23.87 W/cm2 at scalp) on sensory-evoked potentials through 
concurrent EEG recordings [97]. Median nerve stimulations were introduced in this 
study when the tFUS was administered to the scalp region over the somatosensory 
cortex. Their EEG recordings showed that tFUS attenuated the amplitudes of the 
somatosensory evoked potentials, and modulated the spectral content of sensory-
evoked brain oscillations. Mueller et al. [105] researched the ultrasound-
modulatory effect on the EEG phase dynamics of the somatosensory cortex from 
four-channel EEG recordings. The tFUS (Isppa: 23.87 W/cm2) altered the phase 
distribution of intrinsic brain activity in beta-band frequencies and modulated the 
phase rate of beta and gamma frequencies. Lee et al. [106] reported their recent 
human study, in which tFUS (Ispta: 1.5 W/cm2 at transducer, 350 mW/cm2 behind 
the skull) was delivered to the hand region of the somatosensory cortex, using 
subjects’ individual anatomical MR images to guide the transducer over the desired 
region on the cortex. The participating subjects reported the experienced tactile 
sensations, while tFUS stimulations were administered. Two-channel EEG 
recordings from the primary somatosensory cortex revealed that tFUS stimulations 
were capable of evoking potentials in the hand region of the primary 




We will test the hypothesis whether low-intensity tFUS (e.g., Ispta < 1 
mW/cm2) can be used as a controlled perturbation to initiate neural activation. We 
further use electrophysiological source imaging based on multichannel scalp EEG 
recordings to image tFUS-induced brain activation in an attempt to perturb specific 
nodes within a brain network under study to determine the role each node plays 
within the network. The initial results were reported in the BRAIN Investigators 
Meeting held in December 2015. 
1.2.2 Towards the Mechanism of Ultrasound Mediated Neuromodulation through 
Intracranial Electrophysiological Recordings 
For decades, a myriad of brain neuromodulatory approaches, such as deep 
brain stimulation (DBS) [107], transcranial magnetic stimulation (TMS) [108, 109], 
transcranial current stimulation (tCS) [110, 111], transcranial focused ultrasound 
(tFUS) [97, 112, 113], transcranial static magnetic field stimulation (tSMS) [114], 
optogenetics [115, 116], designer receptors exclusively activated by designer 
drugs (DREADDS) etc., have been developed in order to modulate the brain. 
Among these methods, optogenetics receives considerable attention for its 
capacity to selectively stimulation distinct cell-types [117, 118] with high spatial and 
temporal resolution [116]. However, optogenetics heavily relies on invasive 
methods such as transgenic approaches or viral vector transfection, which pose 
practical challenges for translational work in humans [119]. In contrast, TMS 
utilizes a non-invasive, dynamic magnetic field to achieve facilitation or inhibition 
of neural activity [109, 120]. A recent pulse shaping technique has also been 
developed in order to pursue selective neural engagement [121]. Despite the 
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increasing exploration of therapeutic applications using repetitive TMS [122], the 
spatial specificity of the applied induced magnetic field is low limiting its precision 
to modulate specific brain networks. Sharing similar drawbacks, both transcranial 
direct current stimulation (tDCS) [111], and tSMS [114] have been unable to show 
elicitation of neuronal action potentials with high spatial precision instead the 
applied electrical/magnetic field alters the cortical [123] or corticospinal excitability 
[124]. Recently, transcranial alternating current stimulation (tACS) achieved 
noninvasive deep brain stimulation when facilitated with a temporal interference 
technique [125], but its spatial resolution remains to be seen. 
As a promising new technique, low-intensity tFUS can be applied in 
numerous neuromodulation applications due to its high spatial focality (compared 
to TMS and tCS [126]) and its non-invasive nature [127]. During tFUS 
neuromodulation, pulsed mechanical energy is transmitted though the skull with 
high spatial selectivity[97], which can be steered [128] and utilized to elicit 
activation or inhibition through parameter tuning [129, 130]. Pilot studies have 
investigated the neural effects of ultrasound parameters, such as ultrasound 
fundamental frequencies (UFF), intensities (UI), durations (UD), duty cycles (UDC), 
pulse repetition frequencies (UPRF), etc. Besides a few human studies [97, 103, 
113], animal models, such as worms [131-133], rodents [83, 112, 130], rabbits [99], 
swine [134], and monkeys [101], have been utilized to investigate the effects of 
ultrasonic parameters and acoustic-induced effects through behavioral changes 
(e.g. motor response), electrophysiological measurements, or blood-oxygenation-
level-dependent (BOLD) signal, etc. To further achieve selectivity in stimulating 
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brain circuits or even among cellular populations, focused ultrasound is employed 
in combination with specific-neuromodulatory-drug-laden nanoparticles [135], cell-
specific expression of ultrasound sensitizing ion channels [132] or acoustically 
distinct reporter genes in microorganisms [136]. 
Understanding the intrinsic cell-type selectivity of tFUS may be of utmost 
importance for uncovering the mechanism of ultrasound neuromodulation. 
Meanwhile, such mechanistic exploration may reduce the tremendous effort in 
exploring the huge ultrasound parameter space. 
1.2.3 The Trends of tFUS-mediated Brain Stimulation 
1. Targeting at Deep Brain 
As early as 2010, Tufail, et al. had successfully demonstrated that low UFF 
(250 kHz) tFUS with a UPRF of 2 kHz can promote expression levels of brain-
derived neurotrophic factor (BDNF) compared to contralateral hippocampal 
regions [112]. Furthermore, increased neuronal spiking and induced local field 
potential at the targeted hippocampus provided early but direct evidences of the in 
vivo brain responding to low-intensity tFUS (spatial-peak temporal-average 
intensity Ispta: 84.32 mW/cm2). The ultrasound technique allows the tuning of UFF 
to be higher than 250 kHz, thus achieving a better spatial focus (laterally 1.0 mm, 
axially 8.5 mm [137]). Kamimura and colleagues [137] targeted 1.9 MHz focused 
ultrasound (UPRF: 1 kHz, Duty cycle: 50%) to subcortical brain structures, i.e. 
superior colliculus, pretectal nucleus, and hippocampus etc. to trigger reproducible 
eyeball movement and pupillary dilation. The improved spatial specificity produced 
by the 7.6-times higher UFF was demonstrated to lead to consistent behavioral 
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responses comparing to lower UFF scenarios. It was widely recognized that the 
ultrasound penetration depth largely depends on the skull thickness. Due to this 
reason, explorations on large animals and humans for targeting ultrasound to the 
deep brain become highly demanded. Dallapiazza, et al administered three UFF 
levels (1.14, 0.65 and 0.22 MHz) to swine thalamus and demonstrated that low-
intensity focused ultrasound (LIFU, 25-30 W/cm2) can modulate the 
ventroposterolateral thalamic nucleus and further map the thalamic region with an 
observed 2-mm spatial specificity evidenced by epidural somatosensory evoked 
potential (SSEP) as a result of trigeminal, median and tibial stimulations [134]. 
Continuous 20-Watt power high-intensity focused ultrasound (HIFU) was 
introduced in this study to verify the ultrasound targeting, and magnetic resonance 
(MR) thermography was used to monitor the temperature rises in the in-vivo brain 
during both LIFU and HIFU sonications [134]. Legon’s group explored the use of 
tFUS (UFF: 0.5 MHz) modulating human sensory thalamus with scalp SSEP 
readings [138]. The P14 SSEP amplitude was harnessed as a biomarker of 
thalamic response to median nerve stimulation (MNS). Both studies reported 
inhibitory effects induced by the tFUS. Furthermore, researchers have also been 
exploring the possibility of tagging/modulating the brain signal with ultrasound 
waves. 2 MHz tFUS (Ispta: 1.4 W/cm2) with a PRF of 1050 Hz was used to tag the 
living brain signal [139]. Furthermore, demodulated EEG signals share a common 
feature in gamma band as the signal from direct recordings. The non-invasive 
acousto-modulated electrophysiological imaging for the human brain has also 
been conceptualized with EEG/MEG detections [140]. These efforts are expected 
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to pave a new pathway to map the (deep) brain activity with high spatio-temporal 
resolution. 
2. Pursuing High Spatial Definition 
Another trend of the ultrasound neuromodulation investigation is to pursue 
high ultrasound frequency, thus benefiting the spatial resolution for ultrasound 
intervention. Among these efforts, 2.9 MHz UFF was directed by Ye, et al. [130] to 
achieve a smaller focal spot of 0.65 mm onto mice motor cortex, and the efficacy 
of tFUS was evaluated by electromyography (EMG). It was reported that such high 
frequency ultrasound can still elicit motor responses with increased demand of 
transcranial ultrasound energy, but the motor outputs were not consistently 
improved in terms of spatial selectivity as a result of the increased spatial 
resolution. Two months later, Li and colleagues [141] published their 
demonstration that 5 MHz tFUS successfully evoked brain activation evaluated 
with EMG and motion response. With this high UFF, the “equivalent diameter of 
the the stimulation region” can be further decreased to 0.29 ± 0.08 mm. When 
comparing to 1 MHz ultrasound, the brain was observed to have shorter response 
latency for 5 MHz UFF. Undoubtedly, the skull turns to be a significant barrier for 
the high frequency tFUS. Mehić, et al. [98] innovated the ultrasound transducer 
design to allow two independent elements to be driven by 2.25 MHz and 1.75 MHz 
UFFs, respectively, and at the focal spot, a beat frequency at 500 KHz carried by 
a 2 MHz ultrasound wave with 1.5 kHz PRF was eventually utilized to stimulate 
mice brains in a stepwise scanning fashion. Such modulated focused ultrasound 
(mFU) were shown to induce a variety of movements with a 1-mm spatial selectivity. 
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When comparing to another single-element 500 kHz UFF transducer, the mFU 
was reported to achieve higher fluidity and robustness, but less consistency in 
triggering the motor movements. This mFU study proposed a temporal interference 
technique that is able to balance the spatial resolution and acoustic penetration 
efficiency. On large animals and human subjects, Lee and his colleagues 
extensively explore the applications of tFUS with the UFF lower than 300 kHz for 
a better skull penetration. Excitatory effects of the tFUS observed through 
electrophysiological recordings, functional MR images, participants’ reports were 
achieved on sheep sensorimotor and visual cortices [102], human primary visual 
[113], primary [106] and secondary somatosensory cortices [142]. tFUS was also 
harnessed by the group as a medium to transmit sensations between human 
subjects for composing a brain-to-brain interface. Legon, et al. [97] utilized a 
slightly higher UFF (500 kHz) tFUS aiming at primary somatosensory cortex to 
modulate the SSEP observed through EEG. An inhibitory effect of this tFUS 
(spatial-peak pulse-average intensity Isppa: 23.87 W/cm2) was reported, in which 
the MNS-induced SSEP’s amplitude was attenuated by the mechanical energy. 1-
cm spatial specificity was presented, and comparing to the human brain size, the 
lateral resolution of 4.9 mm was observed to be sufficient for modulating the 
cortical functional circuits. In contrast, Hameroff, et al. [103] reported their pilot 
study using B-mode low-intensity transcranial ultrasound (unfocused) at 8 MHz to 
modulate human mental states through the temporal window, and chronic pain 




Chapter 2: High-frequency Magnetoacoustic Tomography with 
Magnetic Induction (hfMAT-MI) for In vivo Cancer Detection 
2.1 Introduction 
In MAT-MI, a pulsed electromagnetic field is delivered by radio-frequency 
(RF) coils to induce eddy current in a target volume of conductive tissues. In the 
presence of an external static magnetic field, the induced current leads to a Lorentz 
force that drives mechanical vibrations within the ultrasound frequency spanning 
from hundreds of kilohertz to several megahertz. Such vibrations induce acoustic 
signals, being subsequently detected by ultrasound transducers. The conductivity 
distribution can be further retrieved by solving a conductivity reconstruction 
problem from the acoustic measurement [33, 38], including vectorizing the 
measurement [143], beamforming the collected ultrasound [45] or modifying the 
coil setup in a multi-excitation scheme (meMAT-MI) [44]. A series of pilot studies 
have been conducted on saline phantoms [144] and biological tissues [43], as well 
as tumor specimens [42]. A reported ex vivo experiment on freshly-procured liver 
tumor specimens has demonstrated the capability of MAT-MI, for the first time, to 
discriminate the cancerous tissue from its surrounding tissue through conductivity 
contrast imaging [42]. Despite significant progresses made on MAT-MI, challenges 
remain, including the limited spatial resolution and the background artifacts. 
In this study, we have developed a system for high-frequency magneto-
acoustic tomography with magnetic induction (hfMAT-MI) by redesigning the time 
response function of the conventional MAT-MI system. This function can be 
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formulated as a convolution of the profile of an electromagnetic pulse and the 
frequency response function of an ultrasound transducer [40, 41, 145]. Based on 
this theory, a high-frequency electromagnetic stimulator and an RF coil with low 
inductance were introduced to shorten and reshape the pulse waveform. Hence, 
both the center frequency of the pulsed magnetic field and the −6 dB bandwidth 
were increased by more than three times at the emitting side; these spectral 
features were then matched by those of the ultrasound transducer at the receiving 
side. By decreasing the wavelength of both the EM stimulation and its induced 
ultrasound signal, the axial resolution was enhanced to one millimeter. Besides the 
improvement of the frequency response, a high lateral resolution was also 
achieved using a rotational scanning regime with an increased equivalent acoustic 
receiving aperture of the hfMAT-MI system for in vivo applications. 
We apply this hfMAT-MI to the in vivo imaging of nude mice bearing human 
breast cancer xenograft hindlimb tumors. We have demonstrated that a 1-mm 
spatial resolution for electrical conductivity contrast imaging has been achieved by 
means of hfMAT-MI, largely benefiting inhomogeneous tissue discrimination and 
early stage tissue anomaly detection [146]. 
2.2 Imaging Theory 
2.2.1 Underlying Physics 
Fig. 1 illustrates a conceptual model of MAT-MI. To deliver the stimulation 
through magnetic induction, a stimulator feeds a coil with a pulsed electrical current 
I(t), and a pulsed magnetic field B1(r, t) is thus induced by I(t) through the object 
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along the z-direction. According to the Maxwell-Faraday equation, 
( , ) ( , )t t t   1E r B r , this magnetic field leads to an electric field E(r, t) that drives 
a rotational eddy current J(r, t) in the object depending on the spatial distribution 
of electrical conductivity σ(r). According to Ohm’s law, the eddy current is 
calculated as J(r, t) = σ(r) E(r, t), and its spectrum features, including the center 
frequency and the bandwidth, are determined by those of I(t). Due to an ignorable 
displacement current comparing to the magnetic induction current in biological 
tissues, this magnetic induction process can be described by (1) for a conductive 
medium based on Ampère–Maxwell equation [33, 34]: 
( , ) ( ) ( , ) ( , ) ( ) 0t t t      J r r E r E r r                               (1) 
where ∇∙ and ∇ are the divergence and gradient operators respectively. The 
Lorentz force resulting from the eddy current in the object is given by 
 ( , ) ( , ) ( ) ( , )t t t  L 0 1F r J r B r B r , where B0(r) is the z-directional magnetic field by a static 
magnet [147]. This force translates the electromagnetic pulse into detectable 
Figure 1. The conceptual model of MAT-MI.  (© 2016 IEEE) 
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mechanical vibrations within an ultrasonic frequency band, which further generate 
acoustic pressure, ( , )p tr , detected by ultrasound transducers scanning around the 
object. In MAT-MI, due to the fact that the physical size of an imaging object (a few 
centimeters) is far less than the wavelength (on the scale of meters) of the pulsed 
magnetic field B1(r, t), this magnetic field satisfies the quasi-static condition, 
allowing the separation of the spatial (r) and temporal (t) components of the 
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in which the acoustic source locates at point r, and cs is the speed of the sound. 
f(t) is employed here to represent the MAT-MI’s time response function. This 
temporal function can be considered a delta function δ(t) with an unlimited-band 
hypothesis [143]. In a limited-band system, however, f(t) is the convolution of the 
magnetic stimulation’s waveform S(t) and the ultrasound transducer’s impulse 
response R(t), i.e. ( ) ( ) ( )f t S t R t   [40, 41, 145]. The observed pressure signal at the 
detecting location rd can be obtained by solving the differential equation (2) using 
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As a solution for the forward problem of MAT-MI, (3) can be used to simulate 
the pressure temporal profiles at different detecting locations. After either 
calculating the pressure signals using (3) in computer simulations or collecting 
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those signals using ultrasound transducers in experiments, the inverse problem 
can be solved using a time reversal approach in order to reconstruct the acoustic 
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Ω is the ultrasound detection surface, θ is the angle between the normal 
vector of Ω at rd and (rd - r), and p''  is the second time derivative of acoustic 
pressure collected at a transducer location. With (4), the acoustic source can be 
reconstructed and further used to delineate the conductivity contrast in the object. 
 
2.2.2 Spatial Resolution 
For a two-dimensional image, its spatial resolution comprises of lateral and 
axial components. In a conventional ultrasound imaging approach, the 3 dB lateral 
resolution depends on the acoustic wavelength and the system’s F-number [149]. 
In MAT-MI, a circular scanning method is used, and when the stepping angular 
distance is less than or equal to the diameter of the transducer, the lateral 
resolution of the MAT-MI imaging system can be determined by: 
3dB # 1w F                                                               (5) 
in which φ is the scanning view measured in radians, and λ is the acoustic 
wavelength. The circular scanning approach used in MAT-MI leads to a much 
smaller F# than that of conventional ultrasound imaging. Using a scanning angle 




For the axial resolution, unlike the pulse-echo regime in conventional 
ultrasound systems, MAT-MI passively detects acoustic signals with ultrasound 
transducers. Thus, its axial resolution can be calculated by [149]: 
axd M                                                        (6) 
in which M is the number of oscillations of the emitting EM stimulation that 
contributes to the center frequency, and in pulse-echo ultrasound imaging, M 
would be more than one to have this axial resolution equal to several wavelengths. 
In order to improve the axial resolution, the system’s time response needs to be 
shortened. By further applying the quasi-static condition and the Biot-Savart law 
integrated over a circular current loop [150] with a diameter of D, for a specific 
location a, (7) shows a dependence of the time response function on the waveform 
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where Q(a, D) incorporates the first and second kind of complete elliptic integral 
functions [151]. The oscillation number M should be as small as 1. 
2.2.3 Computer Simulations 
To test the image resolution that can be achieved by hfMAT-MI through 
computer simulations, as indicated in Fig. 1, the static magnetic field is pointing in 
the z-direction and assumed to be uniform through the imaging area with the flux 
density of 1 Tesla. One set of Helmholtz coils with a diameter of 100 mm and 4 
turns is located in the xy plane at z = 50 mm and z = -50 mm respectively. The 
transient current amplitude is set to be 10 kA/s and the scanning radius is 200 mm. 
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The center frequency of the transducer is 2.25 MHz, and the data sampling 
frequency is set to be 20 MHz. Simulated impulse response for 2.25 MHz 
ultrasound transducer in both time and frequency domains are illustrated in Fig. 
2a-b. To test the capability of the high-frequency MAT-MI in resolving small objects 
and discriminating adjacent regions assigned with different conductivities, a 
simulated phantom is shown in Fig. 2c for finite element analysis (FEA, based on 
PDE toolbox in MATLAB), with the smallest structure and gap between structures 
having the size of 1 mm. From the comparison of acoustic source reconstructions 
in Fig. 2d-e, the detail structures are seen to be better resolved by the 2.25 MHz 
hfMAT-MI than the image results produced by 500 kHz system, in regard of 
reconstructing original object sizes with high fidelity and separating structures 
close to each other (Fig. 2f). The better spatial resolution achieved by the hfMAT-
MI would further allow itself to be applied as a diagnostic tool for breast cancer. 
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The hfMAT-MI concept can also be integrated with the multi-excitation 
scheme. In such an integration (Fig. 3b), besides the conventional Helmholtz coils, 
another two sets of figure-8 coils are needed to generate the pulsed magnetic field 
(B1) along x and y axes and meanwhile the injected current I (1x104 A/s) is required 
to be shorter. This shortened current waveform will increase the center frequency 
Figure 2. Computer simulations of high-frequency MAT-MI (hfMAT-MI). (a)-(b) The simulated 
impulse response of 2.25 MHz ultrasound detection; (c) Simulation phantom with its conductivity
(S/m) distribution for spatial resolution test; (d)-(e) Regular MAT-MI (500 kHz) and 2.25 MHz
hfMAT-MI acoustic source reconstructions; (f) Line profiles of the acoustic source intensities along
y = 22 mm indicated by green lines in (d) and (e).   
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of the induced B1, and further require a high-frequency, matched ultrasound 
detections. To elucidate how the hf-meMAT-MI works, Fig. 3c depicts the 
Figure 3. Computer simulations of high-frequency multi-excitation MAT-MI (hf-meMAT-MI). 
(a) Original simulation phantom to test hf-meMAT-MI. (b) The imaging setup of hf-meMAT-MI. (c) 
Three stimulation patterns and their corresponding induced eddy current distributions, and




stimulation patterns along three axial directions, the induced eddy current 
distributions, and respective acoustic source reconstructions (all based on FEA). 
Based on these intermediate computations, the electrical conductivities of the 
simulation phantom (Fig. 3a) are subsequently reconstructed as in Fig. 3d. The 
line profiles compare the original and the reconstructed results, and it can be 
observed that the hf-meMAT-MI can still detect the boundaries of conductivity 
Figure 4. Computer simulations for coil geometries. (a) A single coil with a diameter of 67.8
mm. (b) A coil array constitutes of 4 small coils with a diameter of 35 mm. (c-d) The magnetic flux 
densities generated by corresponding coil(s) at 30 mm away from the coil planes. (e-f) The multi-
excitation capability by the coil array.  
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change, but the reconstruction of boundary-enclosed region suffers the major 
relative error (0.21). Overall, the correlation coefficient is 0.94. These results 
indicate that to recover the internal conductivity distributions may still need further 
adjustments on, for instance, the relative sizes between the coil and the object. 
The sizes of these simulation phantoms are designed to be commensurate with 
human breasts, whereas making the coils large enough to cover the region of 
interest may raise a practical challenge of a dramatically increased inductance as 
stated by the Wheeler formula,  
𝐿  ∙                                                    (8) 
in which r is the radius to center of windings, n is the turns, w is the width of widings, 
and L is the inductance of the coil. Hence, this would further challenge the pulsed 
current source unit and high-voltage switch. For an application in the hfMAT-MI, 
the size of a coil needs to be balancing between imaging coverage and the coil 
inductance. A coil array configuration may be a solution to meet such needs (Fig. 
4b, d) and additionally, the array may also provide multiple excitations (Fig. 4e, f) 
shown as in Fig. 3c. 
2.3 Materials and Methods 
From the computer simulations, the major advantage of hfMAT-MI is its 
unprecedented spatial resolution in the magnetoacoustic imaging. In order to 
validate the imaging resolution in physical gel phantom, we compare the boundary-
resolving capabilities between a hfMAT-MI system (2.25 MHz) and the previously 
utilized 500 kHz system [38, 41, 152]. The reconstructed acoustic source images 
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from the same saline agar phantom are shown in Fig. 5a-b. It can be observed that 
the 2.25 MHz MAT-MI, with its spatial resolution of about 0.7 mm, resolves the 
Figure 5. Comparisons on imaging spatial resolutions. (a-b) A resolution comparison between 
500 kHz MAT-MI (a) and 2.25 MHz hfMAT-MI models (imaging object is a 20% saline agar
phantom). (c-f) A comparison on imaging spatial resolutions provided by 500 kHz MAT-MI (c) and 
1.5 MHz hfMAT-MI (e) (imaging object is a square-column phantom with 1.5% salinity). The edges 




phantom boundary more precisely than that from 500 kHz system. From Fig. 5a-
b, it can be also seen that the image contrast of 2.25 MHz MAT-MI image is lower 
than that produced by the 500 kHz system (both systems are powered with 440V 
Figure 6. The experimental system of the hfMAT-MI. (© 2016 IEEE) 
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current source), and this is due to the increase in center frequency of magnetic 
induction, the pulsed current in the coil decreases which reduces the magnetic 
stimulation significantly according to the Biot and Savart law. For this reason, 1.5 
MHz hfMAT-MI imaging system was developed to pursue biological tissue imaging 
while receiving benefits from improved spatial resolution without sacrificing 
excessive image contrast. A high voltage source, 25 kV is designed to power this 
1.5 MHz hfMAT-MI for a stronger B1 field and reduced averaging times, thus 
shortening the scanning duration, particularly in the in vivo imaging applications. 
2.3.1 Imaging System 
Fig. 6 presents the hardware setup for the hfMAT-MI experiments. The 
sample is placed on the x-y plane and is immersed in distilled water serving as the 
acoustic coupling medium (cs≈1.5 mm/µs). To produce the high-frequency pulsed 
magnetic induction for biological tissue imaging, a customized high-power high-
frequency stimulator (Applied Pulsed Power, NY, USA) equipped with half-cycle 
stimulation technique (Fig. 7(a)) is used to feed a low-inductance coil (65 mm 
diameter, 800 nH inductance) up to 25 kV, and to minimize ringing effects. As 
presented in Fig. 7(a), the duration of each current pulse is configured to be 680 
ns by the stimulator in order to have a -3 dB bandwidth of 1.3 MHz with a center 
frequency at 1.5 MHz for ( )1B t t  , i.e. the induced rotational electrical field (Fig. 
7(b)), in spectrum. The stimulator initiates triggering and synchronizes with a high-
speed, multi-channel data acquisition card (CSE8482, Dynamic Signals LLC, IL, 
USA), which collects ultrasound signals at sampling frequency of 12.5 MHz to 
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record 4096 data points at each sampling. To detect the MAT-MI signals, the 
ultrasound transducer of the hfMAT-MI system is a customized single-element flat-
immersion type with a diameter of 14.2 mm, a nominal center frequency of 1.5 
MHz, and a -6 dB fractional bandwidth of 76.85% (Olympus NDT, MA, USA). Fig. 
Figure 7. Characterizations of electromagnetic stimulation and ultrasound detection. (a) The 
waveform of the injected pulsed current I(t) having a pulse duration of 680 ns; (b) the waveform of
the induced electrical field detected by a probing coil (radius: 10 mm) at a transverse plane 30 mm
away from the coil; (c) the normalized waveform of the ultrasound transducer’s impulse response;
(d) the calculated time response function f(t) of the hfMAT-MI system; (e) the Welch’s power spectral 
density estimate of f(t), whose center frequency is located at 1.5MHz. (© 2016 IEEE) 
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7(c) presents the impulse response of the ultrasound transducer, and the detected 
acoustic signal is amplified by two-stage ultra-low noise ultrasonic preamplifiers 
with a -3 dB bandwidth of 0.05-2 MHz (5662, Olympus NDT, MA, USA), then is 
filtered by a homemade band-pass filter (1-10 MHz) and a low-pass filter (BLP-5+, 
Cain-Forlaw, NY, USA). The transducer mechanically scans around the sample 
driven by a rotary table (B5990TS, Velmex, NY, USA). This rotational actuator is 
fed by a programmable stepper motor controller (VXM-1, Velmex, NY, USA). In 
addition to steering of the rotary table in the x-y plane, the transducer’s vertical 
location is set by a manual adjuster to align the detecting aperture with the ROI. 
The hfMAT-MI system console software is programmed using LabVIEW 2013 
(National Instruments, TX, USA).  
In Fig. 8(a), the ultrasound gain map [152] is simulated by the Field-II 
software [153]. In order to use a uniform ultrasound gain and also create time delay 
for MAT-MI signals separated from the electromagnetic pulse, the ultrasound 
scanning radius is set to be 160 mm in experiments, and the line profile in Fig. 8(b) 
depicts the gain along the lateral direction 160 mm away from the surface of the 
transducer. Further, using the current amplitude shown in Fig. 7(a) and the coil’s 
inductance value, a simulated magnetic flux density of this pulsed magnetic field 
30 mm away from the coil based on the Biot-Savart law is demonstrated in Fig. 
8(c) and its center line profile is shown in Fig. 8(d). With regards to the static 
magnetic field, a customized NdFeB permanent magnet dipole (Dexter Magnetic 
Technologies, IL, USA) is used to provide a static magnetic field of 0.3-0.6 Tesla 




Figure 8. Characterizations of major physical fields in hfMAT-MI. The simulated gain map of 
the ultrasound transducer is shown in (a) and (b); the simulated pulsed magnetic flux density B1 
30-mm away from the coil is shown in (c) and (d); and the simulated static magnetic field B0 formed
by the dipole is presented in (e) and (f). (© 2016 IEEE) 
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2.3.2 Image Co-registration 
For anatomical referencing, a 64-channel pulse-echo ultrasound system 
(OPEN system, Lecoeur Electronique, Chuelles, France) was employed to image 
the region of interest, including the tumor region, at different heights within the 
animal. This ultrasound system incorporates a 64-element phased-array 
transducer (P7-4, ATL), whose center frequency and bandwidth are 5 MHz and 3 
MHz respectively. The ultrasound data were then acquired with a synthetic 
aperture (SA) method. Using SA beamforming and time-reversal algorithms [154, 
155], an ultrasound pulse-echo image of a corresponding cross section was 
obtained. Considering the ultrasound images as reference, feature-based method 
was used to register the images obtained from hfMAT-MI, and this feature was the 
visible animal plastic holder in both imaging modalities. 
To further delineate internal structures within the tumor, histology was 
conducted after the in vivo imaging studies. The histology images were used to co-
register the electrical conductivity contrast images obtained from the hfMAT-MI by 
aligning affiliated skin tissues. After the mouse was euthanized, the tumor was 
excised together with its surrounding tissues, and was fixed in 10% formalin 
solution for 48-72 hours before transferring to 70% ethanol. The sample was then 
sent to the Biological Materials Procurement Network at the University of 
Minnesota for further dehydration, paraffin embedding, and sectioning. 
Hematoxylin and eosin (H&E) stain was thereafter applied to blue cell nuclei and 
pink cytoplasm. After the preparation of multiple slides, 40× magnification images 
were obtained by a digital microscope (ScanScope XT digital slide scanner, Leica 
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Biosystems, IL, USA). The histologic images were then processed by Aperio 
ImageScope (Leica Biosystems, IL, USA). 
2.3.3 Mouse Tumor Model 
Metastatic human breast carcinoma cell line MDA-MB-435A was used in 
this study. The cells were cultured in Dulbecco's DMEM (Modified Eagle Medium, 
with 584 ml/l L-Glutamine, 4500 mg/l D-Glucose and 110 mg/l Sodium pyruvate, 
Corning Inc., USA), supplemented with 10% FBS (Fetal Bovine Serum, Gibco, 
USA), Pen Strep (100 U/ml penicillin and 100ug/ml streptomycin, Gibco, USA) and 
0.0675 μg/ml human insulin (Sigma-Aldrich, USA). Cells were maintained under 
37°C and 5% CO2. Next, cells were sub-cultured by applying 0.05% trypsin-0.53 
mM EDTA (Invitrogen, USA) for 5 minutes to detach the cells when reaching 70% 
in flasks. Cells in log phase of growth (50-60% confluent) were then harvested for 
tumor inoculation. These cells were rinsed, centrifuged and re-suspended by 
IMEM (Improved MEM without phenol red, serum or other supplements, Gibco, 
USA) twice, onto 2×107 cells/ml cell suspensions. 
All animal procedures and care were approved by the University of 
Minnesota Institutional Animal Care and Use Committee (IACUC) in accordance 
with federally approved guidelines. Female nude mice (6-8 weeks, Athymic Nude-
Foxn1nu, Harlan Laboratories Inc., USA) were injected with 5×106 cells 
subcutaneously over the dorsal flanks near the hind limbs under general 
anesthesia. Experiments were performed throughout the 1-8 weeks after tumor 
seeding when tumor diameter was between 2-15 mm. 
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2.3.4 In vivo Experiments 
After anesthetized by intraperitoneal injection with a mixture of Ketamine 
and Xylazine (100 mg/kg and 10 mg/kg respectively), 1/2 original volume dose was 
given immediately before the hfMAT-MI imaging to extend the sedation period. The 
mouse was placed in a sitting posture inside an equivalent-sized plastic holder. 37℃ 
agar gel was then used to fill the plastic holder to provide good ultrasound coupling, 
maintain the animal’s position, and situate the tumor region 1.5-2 cm away from 
the coil. 1.5% salinity [43] was introduced into this agar gel, so the animal holder 
could be also seen in hfMAT-MI images, facilitating co-registration with ultrasound 
pulse-echo images. 
During hfMAT-MI imaging, the ultrasound transducer scanned around the 
animal with a step size of 1.2°, covering a 180° imaging view. At each detecting 
channel, the signal was averaged over 175 acquisitions using a pulse repetition 
rate of 8.5 Hz. Thus, one in-vivo imaging trial with hfMAT-MI took approximately 
60 minutes. A heating system including a submersible aquarium heater, an air 
vortex heater, and a thermostat was employed to achieve an ambient temperature 
of approximately 36 ℃, to keep the mouse from losing body temperature during 
anesthesia. After the in vivo imaging with hfMAT-MI, the 64-channel ultrasound 
system was used to conduct SA scans for the mouse in the plastic holder at a 
series of layers with increments of 1.5 mm along the z direction, i.e. z = 1.5 mm. 
Then, the mouse was taken out from the plastic holder, wiped dry and placed on 
a heater pad. Next, the tumor size was measured using a caliper before the mouse 
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was recovered from anesthesia. This mouse was then sent back to its cage after 
restoring its motion capability. 
2.3.5 Electrical Conductivity Measurement 
A homemade device, as shown in Fig. 9, was developed to directly measure 
the electrical conductivity of biological tissues at the same center frequency of 
hfMAT-MI. The device employed four unipolar needle electrodes [43, 156] (EL450, 
BIOPAC Systems, CA, USA) with 1-mm tips exposed without 
polytetrafluoroethylene (PTFE) coatings. These electrodes were linearly and 
equally distributed (Spacing: 1.1 mm) on a PTFE beam. The conductivity 
measurement is based on Ohm’s law. After the motion system physically inserts 
Figure 9. The schematic diagram of the four-electrode device for electrical conductivity
measurement of biological tissues. (© 2016 IEEE) 
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the electrodes into a specific location of the tissue, an arbitrary waveform generator 
(33220A, Keysight Technologies, CA, USA) was then used to inject sinusoidal 
electrical current (P-P Voltage: 200 mV, frequency: 1.5 MHz) via electrodes a and 
d into a target location of the tissue. This current was monitored by a current-to-
voltage converter, employing a JFET input operational amplifier (LF356N, Texas 
Instrument, TX, USA). Simultaneously, the voltage across the electrodes b and c 
was detected by a high-speed instrumentation amplifier incorporating a dual-
channel ultralow-noise operational amplifier (AD8599, Analog Device, MA, USA) 
and a precision difference amplifier (AD8274, Analog Device, MA, USA). Thus, 
both the amplitudes of the current and voltage were displayed and measured with 
a digital oscilloscope (DSO7014A, Keysight Technologies, CA, USA). As a result, 
the local conductivity was estimated. Before measuring conductivity values in the 
animals of interest, the device had been calibrated using saline solutions with 
known conductivities. Invasive conductivity measurements were taken 
immediately after euthanizing the mouse through cervical dislocation. 
2.4 Results 
2.4.1 Imaging Quality 
The spatial resolution can be represented by the lateral and axial resolution, 
both of which depend on the acoustic wavelength of hfMAT-MI from equations (5) 
and (6). This wavelength can be calculated from 0sc f  , where f0 is the center 
frequency of the acoustic pressure field p(rd, t). This center frequency, 1.5 MHz, is 
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determined by the Fourier transform of the time response function f(t) as shown in 
Fig. 7(e), leading to the acoustic wavelength  λ = 1 mm. 
In our in-vivo experiment using 1.5 MHz hfMAT-MI, the ultrasound 
transducer scanned 180° (φ = 3.14 rad) around the object of interest, resulting in 
a lateral resolution w3dB of 0.32 mm, whereas from Figure 3(b), the oscillation 
number (M) of the EM stimulation that contributes to the center frequency is 1. This 
leads to an axial resolution of dax = 1 mm. Therefore, the overall imaging spatial 
resolution is determined by this 1-mm axial resolution. To compare the spatial 
resolutions of the 1.5 MHz hfMAT-MI and previous 500 kHz MAT-MI [34, 38, 43, 
157], Fig. 5(c)(e) demonstrates each method’s performance in imaging an identical 
agar phantom prepared in a square column. As indicated in this comparison, not 
only can the imaged edges of the object be reduced from 3 mm to 1 mm as shown 
in Fig. 5(d) and (f), but the EM artifacts were also suppressed approximately 6 dB 
more using the hfMAT-MI, compared with conventional MAT-MI. Both 
improvements are essential for reliable conductivity imaging of biological tissues. 
The capability of EM artifacts suppression is mainly due to engineering upgrades 
in ultrasound detection, magnetic stimulation, and power system design. 
2.4.2 In vivo Tumor Imaging 
Fig. 10 presents an in-vivo imaging study for a tumor bearing mouse. The 
tumor has been propagated at one of the mouse’s hindlimbs for 8 weeks, with the 
size reaching about 1.5 cm3. The sedated mouse maintained a sitting posture in 
the plastic holder as shown in Fig. 10(a) and (b). Three slices in the z-direction 
marked with three dashed lines were selected and imaged by the ultrasound with 
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a phased-array probe, which is also covered by the piston transducer in the hfMAT-
MI. A two-millimeter space step among those slices was achieved by controlling 
Figure 10. An in-vivo imaging study of a tumor-bearing mouse. (a) The top view; (b) the side
view, with three ultrasound scanning slices (c)(d)(e) indicated by three white lines; (f) the in-vivo
image produced by the hfMAT-MI. The yellow boxes represent the propagated tumor region, the
red arrows indicate the tumor-muscle interfaces, and the blue arrows indicate the tumor’s inner
structures, e.g. necrotic core. (© 2016 IEEE) 
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the translation stage. The corresponding ultrasound SA images in Fig. 10(c-e) 
represent cross-sectional views at different heights (z direction) of the same tumor-
bearing mouse. The tumor regions are enclosed with yellow boxes, while inner 
boundaries (i.e. the boundaries between the tumor and internal structures of the 
rest of the mouse body) of the tumor are detected by the ultrasound system and 
indicated by red arrows. Fig. 10(f) is an electrical-conductivity contrast image using 
the hfMAT-MI, in which a complete contour of the same tumor is depicted. Taking 
the advantage of its 1-mm spatial resolution, conductivity variations inside the 
tumor are visualized by the hfMAT-MI image as well. These internal tumor 
structures can also be observed in the ultrasound images, as indicated with blue 
arrows. To further co-register these variations, a histology study of the tumor 
sample followed the hfMAT-MI and ultrasound imaging experiment. Fig. 11 shows 
Figure 11. Histological studies of a tumor sample. (a) A histological slide of the tumor using the
H&E stain; (b) an enlarged view of the histological region marked by the green box in (a), in which
the purple region shows distinguishable features from its surrounding region in pink. (© 2016 IEEE)
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the histological slides using the H&E stain. A necrotic core as the pink, surrounded 
by a “ring-shaped” dark-purple region, can be seen in Fig. 11(a). 
Electrical conductivity measurements at 1.5 MHz using the four-electrode 
device gave a mean of 0.76 S/m (five sample locations) for the necrotic core, 
compared to a mean of 0.62 S/m (five sample locations, measured along a 
transverse direction to the muscle fibers) for the tumor’s adjacent muscle, shown 
in Fig. 12, with a statistically significant difference between the two groups (p < 
0.05) based on a paired sample t-test. As shown in the dark purple in Fig. 11(b), 
which is an enlarged view from an ROI marked by the green box in Fig. 11(a), the 
tumor’s ring-shaped peripheral solid layer, due to its limited thickness, only one 
sample location can be identified and measured by inserting the four electrodes. 
And the measured electrical conductivity for this peripheral layer is 0.44 S/m. From 
these measurements, the conductivity contrast inside the tumor was greater than 
that of the muscle-tumor interface. 
Figure 12. The conductivity (measured by the four-electrode device at 1.5 MHz) comparison 




Figure 13. An in-vivo mouse model study tracking the tumor growth. (a)(b) The tumor 
appearance in the 1st week after a transplantation of the human cancer cell line. (d)(f)(h) are the
ultrasound images of the tumor-bearing mouse in the 2nd, 4th, 6th weeks, and the insets in these
three images show the tumor growth in top views. (c)(e)(g)(i) are the hfMAT-MI images of the 
mouse abdomen and its growing tumor in the 1st, 2nd, 4th, 6th weeks respectively, and more 
specifically, the sizes of the growing tumor can also be estimated. The yellow boxes represent the
regions of the growing tumor, the red arrows indicate the tumor-muscle interfaces, and the blue
arrows indicate the tumor’s internal structural change, e.g. necrosis. (© 2016 IEEE) 
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2.4.3 Tumor Growth Monitoring 
In order to leverage its improved spatial resolution, we used hfMAT-MI to 
image and monitor a growing tumor in a separate mouse over the course of several 
weeks. Yellow boxes are used to mark the tumor regions in Fig. 13. As shown in 
Fig. 13(a), the tumor grew into a “disk-like” protrusion two weeks after the 
transplantation of the breast cancer cells. At this early stage, the diameter of the 
protrusion was about 7 mm, and the height was less than 2.5 mm. Preparation of 
the mouse (1 week after the tumor implantation) for in-vivo imaging with hfMAT-MI 
is shown in Fig. 13(b), with the resulting image shown in Fig. 13(c). This image 
highlighted the small tumor at one hindlimb of the mouse. A significant electrical-
conductivity contrast can be seen between this newly developed tumor and its 
adjacent muscle tissues. This distinct electrical-conductivity boundary (blue arrow) 
indicates that the propagated tumor is restricted subcutaneously. The 2-mm height 
of the tumor can be also estimated from the reconstructed image. 
Along with tumor growth, we started to use the ultrasound SA image to co-
register the electrical-conductivity boundaries detected by hfMAT-MI for the same 
mouse.  Fig. 13(d) and (e) display in-vivo images of the mouse tumor during the 
second week. An inset at the left-bottom side of Fig. 13(d) is a top-view of the 
mouse during imaging, and a yellow arrow indicates the tumor region. The 
geometry of the tumor changes and becomes a small “lump”. However, the 
ultrasound pulse-echo imaging appears less sensitive to the second-week tumor 
compared with hfMAT-MI, because the ultrasound image does not explicitly 
differentiate the tumor region from its surrounding soft tissues, while the image 
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from hfMAT-MI preserves and highlights the tumor “lump”. Moreover, Fig. 13(e) 
shows that the tumor-muscle interface (blue arrow) starts to lose the high contrast 
obtained in images from the first week. When the tumor entered into its fourth week, 
its size had approximately doubled compared to the two-week mark. In Fig. 13(f), 
some of the tumor boundaries start to evolve in the ultrasound image, whereas a 
sharp boundary is detected using hfMAT-MI, depicted in Fig. 13(g). In addition, 
both sets of images reveal that the tumor gets less homogeneous over time in 
terms of both the acoustic characteristics and the electrical properties of the tumor 
tissue, reflecting internal structural change related to tumor necrosis. The red 
arrows in Fig. 13(f) and (g) point to the suspected necrotic region of interest. At the 
sixth week, boundaries of the tumor were more apparent than previous 
observations in the ultrasound image shown in Fig. 13(h). However, similar to the 
weak signal from the tumor-muscle interface introduced in Fig. 10(f), the electrical-
conductivity contrast was decreased on the margin (blue arrow), shown in Fig 13(i). 
By the fourth week, besides the expansion of the tumor’s external geometry, its 
internal structure had become even more complicated, as more conductivity 
variations are apparent in the hfMAT-MI images. At this late stage, a necrotic core 
(red arrow) had developed inside the tumor, which was also co-registered with 
histology. The electrical conductivity of the tumor was also measured using the 
four-electrode device before the tumor sample was sent for the histology study. By 





Tissue conductivity imaging using MAT-MI was proposed in 2005 [33] with 
a sonography-comparable spatial resolution. In the present study, for the first time, 
we present the equations for quantifying the 2-D MAT-MI imaging spatial resolution. 
Previously, by applying Rayleigh criterion, a spatial resolution of 1.51 mm was 
claimed through parallel-line-source phantom experiments, which used a high-
power magneto-acoustic system with a center frequency of 460 kHz [41]. In the 
present study, we have demonstrated that by using high-frequency pulsed 
magnetic induction and its coupled acoustics, we can achieve a spatial resolution 
of 1-mm while obtaining reasonable contrast measurements compared with 
existing MAT-MI methods [41-43, 76]. To compare the spatial resolution with the 
reported value in [41], the minimum resolvable spatial detail using hfMAT-MI is as 
small as 0.53 mm if applying Rayleigh criterion. More specifically, the 2-D MAT-MI 
imaging spatial resolution is divided into the axial and lateral resolutions. We show 
that both of them depend on the frequency response of the imaging system. 
Furthermore, by using rotational scanning in MAT-MI, the 2-D imaging spatial 
resolution appears to be determined only by the axial resolution. This may not be 
true for applications using limited views, in which the lateral resolution may become 
the “bottle neck”. It is also worthwhile to note that both the element size of an 
ultrasound transducer and the distance from this transducer to an imaging object 
can affect the sensitivity and the imaging resolutions, among which the elevational 
resolution is another fixed property of the transducer to resolve structures in the z-
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direction and should be considered in a 3-D imaging case. In our 2-D imaging work, 
as the transducer uses a single round, flat sensing element, its elevational 
specification is similar to the simulated line profile in Fig. 4(b) (W3dB = 12 mm). This 
12-mm specification is used to align the transducer with the ROI, i.e. transplanted 
tumors. To improve this z-directional resolution, focused ultrasound transducers or 
an acoustic lens [158] can be used. In summary, this work addresses significant 
technical challenges of in vivo magneto-acoustic imaging and paves the way for 
future work in early detection of cancer using hfMAT-MI. 
In this in-vivo, small-animal breast-cancer model study, we have shown the 
capability of MAT-MI in discriminating tumors from normal tissues, identifying 
internal tissue structures and tracking tumor growth for the first time. The imaging 
contrast mechanism (i.e. conductivity difference) was verified by measuring fresh 
tumor and its neighboring muscles with our lab-made device. The propagated 
tumor in Figs. 8 and 9 had been grown for 8 weeks on one mouse subject, and the 
resulted tumor in Fig. 10 was on another mouse, with Figs. 10(h)(i) and 11(a) 
showing the tumor images in week 6. Comparing these two cases, the late stage 
of the tumor was proved to have high inhomogeneity of electrical conductivity, and 
the tumor necrotic core expressed much high conductivity value due to its fluidic 
state with decreased cell membrane structures seen from histology results and 
increased ion concentration in extracellular space. Besides, we also found that 
when the tumor was grown for 6 weeks as imaged in Fig. 10(h)(i), the electrical 
conductivity contrast decreased at the tumor-muscle interface. This phenomenon 
may be explained by an observation when doing tumor anatomy after euthanizing 
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the mouse subject; as a result, we noticed that the tumor had very close tissue 
connections to the adjacent muscle (photos not included), whereas such tissue 
connection was relatively loose, and gradually getting close during the initiative 
four weeks after tumor transplantation, and this was verified using another two 
mice respectively sacrificed in week 2 and week 4. Further cancer biology study is 
needed to understand the mechanism. 
Through the in vivo experiments, as small as a 20% conductivity difference 
was able to be imaged with our hfMAT-MI system.  In clinical breast cancer imaging, 
better contrast (the conductivity measured at 1.5 MHz of a developing breast tumor 
is 10 times higher than that of normal breast adipose tissues [4]) may be presented, 
which would make our magneto-acoustic imaging method more sensitive in 
depicting the margin of a breast tumor. However, further tests are needed to 
address more complicated structures in the human breast than those in an animal 
model. Despite this challenge, the potential of distinguishing breast cancer tissue 
from healthy tissues makes hfMAT-MI a promising imaging tool for assisting 
diagnosis of early-stage human breast cancer. One significant improvement of 
hfMAT-MI compared with conventional methods is its increased sample space (Fig. 
2) between the magnetic dipole, allowing one human breast to be fit into the 
imaging setup without any difficulties. Moreover, an improved hfMAT-MI system 
employing multiple receiving ultrasound transducers is also being developed to 
dramatically shorten the 2-D imaging time down to 10 minutes, which is beneficial 
when considering subject’s comfort in potential clinical applications. Overall, 
besides the intrinsic merits of MAT-MI, such as being non-invasive, good imaging 
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depth, and inherent immunity to the “shielding effect” [33], this work demonstrates 
the integration of tissue electrical-conductivity imaging with pulse-echo ultrasound 
imaging to provide both structural and functional information for the first time. This 
combination suggests the feasibility of integrating hfMAT-MI with conventional 
ultrasound imaging for multi-modal, early diagnosis of human breast cancer. The 
high-frequency technique introduced in hfMAT-MI also lays a foundation for further 
detecting the anisotropic property of biological tissues with the 1-mm spatial 
resolution. The multi-excitation MAT-MI technique have been validated through 2D 
experiments [44] and 3D trials [158]. Besides reconstructing the conductivity 
distribution, the multiple coil sets and the corresponding algorithms introduced by 
the multi-excitation research can also be used to compute the conductivity 
gradients along both x and y directions, and potentially along z direction if 
ultrasound elevational resolution can also be further improved. 
Compared to other clinically-available imaging modalities, the imaging 
contrast of hfMAT-MI still needs to be further improved. One approach would be 
to introduce a strong static magnetic field to address this issue. In fact, several 
pilot imaging tests on pork phantoms have been conducted employing a 9.4T MRI 
magnet and a 500 kHz high-power stimulator [159]. Besides the increased costs, 
the system assembly of MAT-MI in an MRI machine is still challenging for in vivo 
experiments. Another potential approach is to redesign the RF coil that generates 
the pulsed magnetic field. hfMAT-MI could utilize low-inductance coils to form a 
large coil array, allowing an even higher current amplitude flowing through than 
that achieved in Fig. 3(a). This improvement on the coil engineering is believed, 
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on the one hand, to increase the pulsed magnetic flux density, thus inducing a 
stronger instantaneous electrical field than that presented in Fig. 3(b). On the other 
hand, this would expand the effective imaging area, effectively reducing the 
inhomogeneity of the pulsed magnetic field. Due to the short rise time (less than 1 
μs) and the low peak magnetic flux density (less than 0.1 T at 30 mm away from 
the coil), the current level and waveform employed in hfMAT-MI is believed to be 
safe avoiding nerve stimulation.  
In the present study, breast cancer bearing mice were used as a cancer 
model. Tumors were induced by injecting MDA-MB-435A (LCC6) cells into the 
hindlimbs of the mice. This cell line is an ascites model of MDA-MB-435, which 
was derived at M.D. Anderson Cancer Center, Houston, TX, USA in 1976 from the 
pleural effusion of a 31-year-old female with metastatic, ductal adenocarcinoma of 
the breast [160]. Ever since, the MDA-MB-435 cell line has been in extensive 
worldwide use among established laboratories as a model for human breast 
cancer. The xenograft tumor formed in immune-deficient rodents (e.g. T-cell 
deficient athymic nu/nu mice) not only retains genetic and phenotypic properties 
of its human counterparts, but also serves as a cost-effective in vivo model for 
understanding tumor biology and mimicking critical elements of disease 
progression [161, 162]. However, even though breast cancer cell lines and their in 
vivo studies provide considerable insights into breast carcinoma, a few cell lines 
are not enough to characterize all types of human breast cancer with distinct 
features [163]. As for the MDA-MB-435 cell line used in this study, questions have 
been raised that gene expression analysis of the cells produced some microarrays 
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in which MDA-MB-435 clustered with cell lines of melanoma origin [164-166]. We 
are aware of the debate about the origin of this cell line [167] and despite these 
speculations, strong evidence has been presented reiterating that MDA-MB-435 is 
of breast cancer origin [168] and may be used as “an excellent model for studies 
of highly malignant and dedifferentiated breast cancers” [165]. However, we realize 
that discussions concerning the cell line’s genetic origin are outside the scope of 
this paper, which focus more on demonstrating the capability of high-resolution in 
vivo imaging of cancer using conductivity contrasts.  More work has been planned 
on testing with in-vivo models using different cancer cell lines as well as procured 




Chapter 3: Contrast-enhanced Magnetoacoustic Imaging with 
Magnetic Nanoparticles 
3.1  Introduction 
The contrast presented by MAT-MI can be further enhanced by introducing 
the magnetic nanoparticles, thus leading to a high sensitive detection of cancerous 
tissue. Recently, several ultrasound-based nanoparticle imaging techniques have 
been introduced in which a secondary effect of the nanoparticles is being used to 
indicate their presence. Magnetoacoustic tomography (MAT) is an imaging 
modality used to reconstruct the distribution of magnetic nanoparticles (MNPs) 
based on acoustic pressure induced from magneto motive force. In this method, 
we apply a short, microsecond duration magnetic pulse to the tissue with MNsP. 
This leads to a short pulsed magneto motive force acting on the MNPs which gives 
rise to acoustic vibrations that spread throughout the medium. These acoustic 
vibrations are at the same frequency as the dynamic magnetic field, which is 
chosen to match the ultrasound frequency range. This allows recording of these 
acoustic waves with ultrasound transducers which are placed around the object. 
This measured signal can then be used to reconstruct the acoustic source 
distribution in the object by using possible ultrasound imaging approaches which 
leads to the reconstructed images having a good resolution of the ultrasound 
imaging method and good imaging depth in soft tissue. In the present study, we 
demonstrate our work on in-vivo imaging of the iron oxide based nanoparticles 
(IONP). The particles are chosen to be small (10 nm) which leads to these particles 
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having superparamagnetic properties. This allows the particles to have good 
stability in colloidal solutions. Using these particles with a concentration of 4 mg 
Fe/ml injected into the LNCap prostate tumor propagated over the hind limb of the 
mouse, we have performed in-vivo imaging of these nanoparticles. These in-vivo 
tumor images are co-registered with ultrasound imaging and demonstrated the 
MAT method’s capability to assess IONP’s presence and distribution in the tumor. 
3.2 Imaging Theory 
3.2.1 Magneto-acoustic Signal Generation 
In magneto acoustic tomography based iron oxide nanoparticle detection, a 
time varying magnetic field 𝑩𝟏 𝒓, 𝑡  is applied over the object space Ω. This field is 
generated by applying a pulsed current through coils placed in the xy plane as 
seen in Fig. 14, and this gives rise to magnetic fields which are primarily along the 
z direction over the object space. Also, when the applied current pulse duration is 
in the micro second range, the corresponding magnetic field is in the MHz 
frequency range. In biological tissue, such a field can uniformly penetrate through 
the object and can be considered to be quasi static [45, 169] and fully determined 
by the coil geometry carrying the pulsed current. This allows the separation of the 
spatial and temporal components of the magnetic field as follows 
 𝑩𝟏 𝒓, 𝑡 𝑩𝒛 𝒓  𝑓 𝑡                                       (9) 
Where 𝑩𝒛 is the magnetic field acting along the z direction in space, 𝑓 𝑡  is the 
time dependence of the field. The magnetic nanoparticles present in such a field 
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experience the magneto-motive force along the z direction as described by the 
following equation [74, 170]: 
𝑭𝒎 𝐵  
𝑩𝒛  𝑓 𝑡 ,                                     (10) 
Where 𝜒  is the magnetic susceptibility of the particles, 𝑉  is the volume of the 
nanoparticles and 𝑓  is the volume fraction of the nanoparticles and 𝜇  the 
magnetic permeability constant. 
For a biological tissue medium behaving as a inviscid fluid, the linearized 
Navier-Stoke’s equation describing the relationship of the pressure wave and the 
applied force is as follows [22, 39, 69]: 
𝜌 𝒗 ∇𝑝 𝑭𝒎                                            (11) 
where 𝑝 𝒓, 𝑡  is the pressure, 𝒗 𝒓, 𝑡  is the velocity at a point 𝒓 in the medium, 𝜌  
is the density of the medium. 
Figure 14. Schematic diagram of magnetic nanoparticle imaging using magneto acoustic 
tomography method with a short pulsed magnetic field. (© 2016 Elsevier) 
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Taking the divergence of the above equation and combining it with the 
continuity equation in the medium for such an acoustic wave, 𝛽 ∇ ∙ 𝒗 0   
gives the wave equation describing the pressure distribution:  
∇ 𝑝 ∇ ∙ 𝑭𝒎                                           (12) 
Where 𝛽  is the compressibility of the medium, 𝑐  which is ~ 1500 m/s for 
biological soft tissue.  
The pressure in the medium is given by the Green’s function solution to 
Equation 12: 
𝑝 𝒓, 𝑡 ∭ 𝑑 𝑟 ∇ ∙ 𝑭𝒎 𝒓 , 𝑡 𝐺 𝒓, 𝒓 , 𝑡              (13) 
Where 𝒓  is the location of the acoustic source, 𝒓 is the location detector, ∇  
implies derivative with respect to source space 𝒓′, the Green’s function for this 
solution 𝐺 𝒓, 𝒓 , 𝑡  where 𝑅 |𝒓 𝒓 |. The volume integration is carried 
out over the acoustic source distribution in the object space Ω. This equation gives 
the observed pressure for an impulse source, i.e., a source with its time function 
as  𝛿 𝑡 . An induced acoustic source field with time dependence ℎ 𝑡  and the 
transducer impulse response 𝑟 𝑡  gives rise to an observed pressure  𝑝 𝒓, 𝑡 ⊗
ℎ 𝑡 ⊗ 𝑟 𝑡 , where ⊗ is the convolution operator. The Green’s function for this 
time dependence can be written as   𝐺 𝒓, 𝒓 , 𝑡 , where  ℎ𝑟 𝑡  ℎ 𝑡 ⊗
𝑟 𝑡  [152]. 
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3.2.2 Image Reconstrcution 
Equation 13 shows the pressure signal received by an ideal point receiver. 
With such a receiver collecting pressure signals on an aperture enclosing the 
object (Σ) in an acoustically homogeneous medium, the initial pressure distribution 
is related to the acoustic source as   ∇ ∙ 𝑭𝒎 [28], can be determined by 
time reversing the acoustic waves [19]. This gives the acoustic source distribution 
in the medium as: 
   ∇ ∙ 𝑭𝒎 𝑟 ∬ 𝑑𝑆 𝒏 ∙
𝒓𝒅 𝒓
| |
 𝑝" 𝒓𝒅, |𝑟 𝑟|/𝑐∑                (14) 
where 𝒓𝒅 is a point on the detection surface, 𝒓 is a point in the object space, and 
the double prime represents the second derivative over time. In this equation a 
term corresponding to the first derivative is neglected as its contribution is 
negligible compared to the second derivative term [33, 39]. 
3.3 Materials and Methods 
3.3.1 Imaging System 
Fig. 15A shows the schematic diagram of the magneto acoustic 
tomography imaging system for the mouse experiment. In this setup, a coil 
consisting of 3 turns of wire placed in the same plane, with a maximum outer 
diameter of 70 mm and 2 mm thickness (APP Inc., Freeville, NY, USA), is used to 
apply a microsecond long magnetic pulse to the object region. This coil is placed 
horizontally very close to the tank wall to maximize the magnetic field in the object 
region. It is driven by a customized magnetic stimulator using a capacitor and high 
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power switch to apply a pulsed current to generate the magnetic field. This 
capacitor in the stimulator can be charged from 0 to 24 kV applied to the coil by 
the solid state switch (APP Inc., Freeville, NY, USA). Fig. 15B shows the current 
through the coil at 24 kV capacitor voltage. The force contribution due to the 
magnetic field at this voltage is  B  26 T /m  leading to a force of 
~2.6 10  𝑁 per particle giving rise to a pressure of ~ 1.5 Pa in the medium from 
the previously described method in Hu and He [76]. However, due to the large 
current through the coil, electromagnetic interference is observed at the ultrasound 
signal measuring transducers. In the imaging experiments the charging voltage is 
set to 16 kV giving optimum SNR for the ultrasound recording. 
The imaging region of the object and the transducer with a diameter of 25 
mm and a nominal peak frequency of 0.5 MHz (TRS ceramic, PA, USA) were 
immersed in the plastic tank of distilled water. The transducer has a bandwidth of 
60% around the center frequency and the scanning performed using a rotational 
stage (B5990TS, Velmex Inc., USA) over 180 degrees with a step size of 2 degrees 
around the object. Piezoelectric signals collected by the transducer were amplified 
with a low-noise ultrasound amplifier and a bandpass filter with 75 kHz to 1 MHz 
cutoff frequencies (5660B, Olympus, MA, USA, and VP2000, Reson, Denmark) 
before entering the data acquisition system which acquired 2048 data points for 
each channel with a 5 MHz sampling rate. The data are averaged 200 times for 
each channel and recorded in the PC also synchronizing the magnetic stimulation, 
the data acquisition timing and the motor's position. 
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Additionally, after the magneto acoustic imaging experiment, pulse echo 
imaging of the object is performed with a commercial ultrasound scanner, a 64-
channel US system (OPEN system, Lecoeur Electronique, Chuelles, France). The 
US system was connected to a 64-element US phased-array transducer (P7-4, 
ATL) with the elements arranged in a linear array configuration with interelement 
spacing of 0.18 mm. The center frequency of the transducer is 5 MHz; its 
Figure 15. Experimental Setup of Magneto-acoustic Tomography. (A) Schematic diagram of
the MAT imaging setup. The coil placed close to the tank is used to deliver the pulsed magnetic
field to the imaging object. (B) The waveform of the applied current to the coil generates the micro
second long magnetic pulse. (© 2016 Elsevier) 
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bandwidth is 3 MHz. This system is operated in the pulse echo mode with 
transmission from each channel and corresponding echo recording from all 
channels forming one measurement then repeated for all 64 elements. These data 
are then beamformed using the synthetic aperture based back-projection algorithm 
to reconstruct the ultrasound image corresponding to the imaging cross section of 
the MAT method [69, 171]. 
3.3.2 Mouse Tumor Model Preparation 
For the in-vivo imaging experiments, prostate tumors are introduced over 
the hind limb of seven-week old nude mice by injecting LNCap cells into the limb. 
These LNCap cell lines commonly used in cancer research come from human 
prostate adenocarcinoma [172]. For inducing the tumor, 1 million cells suspended 
in 0.1 mL Matrigel matrix (50% Matrigel and 50% LNCaP growth medium) are 
subcutaneously injected into the hind limb of each of the nude mice weighing ~ 24 
g. The tumors grow for 4 to 6 weeks and approximately reach a diameter of 5–10 
mm. These mice are then used for the experiments. 
3.3.3 Magnetic Nanoparticles and In vivo Imaging Experiment 
For the experiments, we use commercially available, water soluble ferrofluid 
superparamagnetic nanoparticles, EMG 308 (Ferrotec, NH, USA). The EMG 308 
(Xnp  = 0.5) consists of Fe2O3 with a particle diameter of ~15 nm in the suspension 
[76](https://ferrofluid.ferrotec.com/products/ferrofluid/emg). Transmission electron 
microscopy (TEM) image of aqueous EMG-308 is shown in Fig. 16A and the 
histogram of the particle size distribution is shown in Fig. 16B. For the mouse 
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imaging experiments, an aqueous solution of EMG 308 is used with an IONP 
concentration of 4 mg Fe/mL; a volume of 50–75 μL is injected into the center of 
the tumor with a single application. 
The mouse in the imaging experiment setup is seen in Fig. 15A. As seen in 
this figure, the anesthetized mouse with the tumor is placed inside a cup, in a sitting 
position, and fixed with a cooled agar gel placed around the tumor region in the 
cup. Also, since the tumors are present over the hind limbs, they are less affected 
by the cardiac motion. The cup region with the tumor is immersed under warm 
water for coupling of the acoustic signal with the ultrasound transducer, while the 
head of the mouse is held outside the water to allow for breathing. Additionally, a 
Figure 16. Characterization of the magnetic nanoparticles. (A) Room temperature transmission
electron microscopy (TEM) images of aqueous EMG-308 IONPs were acquired with ab FEI Tecnai 
T12 microscope (FEI, Inc., Hillsboro, OR) operating at 120 kV. A 200 mesh copper grid with formvar
and carbon supports was dipped into a ~ 1 mg Fe/ml IONP suspension, then removed and allowed
to dry before imaging. (B) The histogram of the longest radius and the radius normal to it were
measured using Image J (NIH). (© 2016 Elsevier) 
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heater with a thermostat is used to maintain the temperature (~36 °C) in the tank 
during the experiment. The mouse is anesthetized using IP injection of mixture of 
ketamine 100 mg/kg and xylazine 10 mg/kg for the imaging experiments. After the 
imaging experiment, the mouse, under anesthesia, is sacrificed by cervical 
dislocation and the tumor excised for histological analysis. The histological section 
is stained with Prussian blue stain and counter stained with nuclear fast red. These 
experiments have been approved by the Institutional Animal Care and Use 
Committee (IACUC) for animal research at the University of Minnesota. 
3.3.5 MAT Image Reconstruction 
For the image reconstruction we use the modified time reversal algorithm 
presented in the theory section. It is seen through studies of ultrasound image 
reconstruction theory [173, 174] that there is data redundancy in the measured 
ultrasound signal from around the object. A half view angle corresponding to 180 
degrees of scanning for data collection around the imaging object is sufficient for 
the tomographic reconstruction. In the present study, we used 180-degree scans 
to avoid potential signal distortion from the ultrasound pressure waves traversing 
through the abdominal regions of the mouse reaching the transducer possibly 
containing gases. Also, the reduced scan angle leads to reducing the scan time. 
The ultrasound transducers available have a limited bandwidth around the center 
frequency of about 60%-70% acting as a bandpass filter on the received pressure 
signal as seen in the theory section. This filter, as seen in the frequency domain, 
creates a signal windowing function around the center frequency and behaves 
much like a Gaussian low pass filter combined with the temporal derivatives 
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needed for ultrasound image reconstruction as seen in Equation 14 [175]. The 
temporal derivatives of the measured pressure signal used in the image 
reconstruction could lead to amplification of high frequency noise present. 
However, as the band pass filtering of the transducer already contains the temporal 
derivatives, we further modify the image reconstruction in Equation 14 by 
substituting the pressure signal p, instead of its derivatives p ", for a given 
transducer location. 
In the experiments, the time varying magnetic field leads to electromagnetic 
interference (EMI) at the ultrasound transducer. This continues for a certain 
duration due to the turn off transients associated with the stimulator and the 
impulse response of the transducer. The observed EMI signal in the experimental 
data has significant, low frequency variations. This noise on time reversal leads to 
slow varying spatial signals interfering with the reconstruction of the low spatial 
frequency component of the acoustic source distribution. This leads to errors in 
IONP distribution imaging, so the received acoustic signal is further bandpass 
filtered to eliminate most of the low and high frequency noise. A simple filter 
implemented for this purpose in frequency domain is 
𝐹 𝑓
1,        100 𝑘𝐻𝑧 𝑓 900𝑘𝐻𝑧
0,           𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒                       
                          (15) 
I/Q demodulation based envelope detection is performed on the filtered 
signal, and the ultrasound image reconstruction algorithm as described above is 





3.4.1 Contrast-enhanced MAT with MNPs 
We performed magneto acoustic tomography experiments in live nude mice 
using the proposed system. In the experiment result seen in Fig. 17, we used an 
agar gel phantom with nanoparticles embedded to test the signal due to the 
magneto motive force. The phantom as seen in Fig. 17, A consists of 1% agar gel 
with a 1.5 mm circular agar gel inclusion infused with iron oxide nanoparticles. A 
thin piece of plastic is placed between the inclusion and the background to prevent 
diffusion of nanoparticles. The concentration of nanoparticles in the inclusion is 
varied from 8.3, 4, and 1.8 mg Fe/ml to perform three different experiments. The 
MAT image of the phantom is reconstructed as described in the methods section. 
The intensity of the signals used in the image reconstruction is normalized to the 
maximum signal measured in the experiment. The reconstructed image 
corresponding to the inclusion concentration of 8.3, 4, and 1.8 mg Fe/ml is shown 
in Fig. 17B-D respectively. It can be seen then that the image intensity varies with 
the concentration of nanoparticles. Also, the average image intensity and variation 
in the inclusion region for the three phantoms were plotted with respect to the 
concentration as seen in Fig. 17E, which shows the linear dependence of the 
magneto-motive signal on the nanoparticles concentration. In addition, the 
resolution of the imaging system is ~1.5 mm [159, 176]. The effect of this on the 
reconstruction leads to distortion in the image of the object with the image intensity 
varying through the inclusion region as seen in the Fig.17. 
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Experiments were also performed to image five mouse tumors with the 
nanoparticles injected as described in the methods section. Fig. 18A is the imaged 
Figure 17. Imaging experiment with a small circular inclusion of IONP at different
concentrations in 1 % background agar gel. (A) Top view photo of the imaging 
object. (B , C , D) MAT images of the object with IONP concentration of ~ 8.3, 4.0, 1.8 mg Fe/ml




mouse and the tumor region, about 7 mm, in the experiment phantom with the 
corresponding orientation of the scanning transducer and applied magnetic field. 
The signal collected from this location is processed as described in the methods 
section, and this envelope detected signal is shown in Fig. 18A. It can be seen 
from the figure that strong signals are present around 183–187 μs corresponding 
with the location of the tumor region; the spread in the signal of around 4 μs 
corresponds to the distribution of the nanoparticles in the tumor. The background 
signal strength is approximately 3–4 times lower than the IONP signals. 
Histological slices of the tumor stained with Prussian blue can be seen in Fig. 18B, 
confirming the presence of the injected nanoparticles. The measured magneto 
acoustic signals are used to reconstruct the distribution of the IONP using the back 
projection algorithm. The image reconstruction result can be seen in Fig. 19. The 
ultrasound (US) image of the mouse is shown in Fig. 18A showing the imaged 
cross-section with the tumor present superficially over the right hind limb of the 
mouse. As the pulsed magnetic field is not applied during the imaging, the signal 
from the IONPs, due to the magneto motive force, is absent. The intensity of 
ultrasound speckle distribution is fairly uniform throughout the reconstructed image. 
The MAT image showing the IONP distribution can be seen in Fig. 18B. The noise 
baseline of the reconstruction from the imaging system is used as the floor of the 
reliable signal that can be measured and masked out from the MAT image. Fig.18C 
shows the overlaying of the MAT image on the ultrasound image of the mouse; the 
IONP signal is strongly present in the region over the hind limb of the mouse 
indicating the tumor. Fig. 18D shows the tumor region with the overlaying MAT 
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image. From the non-uniform intensity of the reconstructed IONP distribution, we 
can also see the heterogeneous distribution of the nanoparticles due to the IONP 
injection in the tumor region, seen in the histology from Fig. 17B. 
To further validate the MAT method for in-vivo IONP imaging, four more 
tumor images were obtained as shown in Fig. 20. Fig. 20A-D shows the ultrasound 
image of the tumor regions without the magnetic pulse stimulation. The 
corresponding images with IONP distribution estimated from MAT images are 
shown in Fig. 20E-H. The presence of the IONP in the mouse can be clearly seen 
in the MAT images. However, as the IONP distribution is not uniform from the 
injection, the intensity distribution of the reconstruction varies throughout; and as 
Figure 18. MAT signal and tumor histology. (A) Top view photo of the imaging object showing
the tumor region in the mouse and the corresponding MAT signal due to the embedded
IONPs. (B) Histological cross section of the tumor injected with IONPs. The section is stained with 
Prussian blue stain and counter stained with nuclear fast red with the blue areas indicating the
IONPs. (© 2016 Elsevier) 
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seen in Fig. 20H from the smaller region of IONP in the reconstruction, the dose 
of the nanoparticles retained in the imaging region could be small.  
3.4.2 hfMAT-MI for High Resolution Imaging of MNPs 
Furthermore, as presented in Chapter 2, the developed hfMAT-MI system 
is proved to image samples with MNPs inclusions to obtain better spatial 
resolutions for imaging the magnetic nanoparticles. In this scheme, from the 
mathematical expression by Equation 10, both the dynamic and static magnetic 
Figure 19. Ultrasound and MAT images. (A) Ultrasound image (US) of the mouse corresponding 
to the magneto acoustic tomography imaging cross-section showing the tumor on the right hind
limb of the mouse. (B) Magneto acoustic tomography image of the magnetic nanoparticles injected
in the mouse tumor. (C) Combined MAT and ultrasound image indicating the tumor with the 
nanoparticles present in the region. (D) Reconstructed image area highlighting the tumor region.
(© 2016 Elsevier) 
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fields and their gradients may generate magneto-motive force jointly on MNPs, 
which is much stronger than the Lorentz force in magnitudes. These two acoustic 
sources exist in one scanning, and can be recorded simultaneously by ultrasound 
transducers and further reconstructed with the hfMAT-MI technique. Phantom 
experiments with MNPs’ gel inclusion indicate that the spatial resolution of 
magnetic nanoparticle imaging with the MAT is enhanced, which is used to better 
determine the distributions of both MNPs and the electrical impedance in the 
phantom (Fig. 21A). Moreover, from the study on a phantom with MNPs fluid 
inclusions, the external static magnetic field may give rise to MNPs aggregation 
and thus form MNPs clusters (Fig. 21B-D). This geometric change may also lead 
to an increased magnetic momentum of the nanoparticle clusters, thus a higher 
Figure 20. MAT image of four tumors. (A – D) Ultrasound image corresponding to the pulse echo 
imaging method without the applied magnetic pulse. (E – H) MAT images overlying the ultrasound
image showing the IONPs present in the tumor region. (© 2016 Elsevier) 
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magnetic susceptibility, which further results in an enhanced magneto-motive force. 
This phenomenon can further contribute to the imaging contrast and improve the 
signal-to-noise ratio of magnetic nanoparticle imaging with magnetoacoustic 
methods. Fig. 21B-D demonstrates the very first image that presents the 
distributions of MNPs using the resolution of 2.25 MHz ultrasound. 
In this imaging study, I used a home-made stimulator powered with 440 V, 
and scanned the phantom at 655 angles with a step size of 0.5 degrees. The 
ultrasound scanning radius was 206 mm. 
Figure 21. 2.25 MHz hfMAT-MI image of gel phantom with MNP inclusions. (A) Physical 
phantom consists of agars with two salinity (20% and 1%), and two cylindrical inclusions of EMG
308 MNPs with the ferrum concentration of 48 mg/mL. (B) A magnetoacoustic image reconstructed
with 2.25 MHz hfMAT-MI. The sharp boundaries of the agar phantom have been captured as




Furthermore, I applied the developed 1.5 MHz high-power hfMAT-MI to 
image the MNPs in an agar phantom (Fig. 22A) and, interestingly in a mouse 
carcass to explore the feasibility of transcranial detection of the magneto-motive 
force-induced ultrasound signal (Fig. 22C). 
Although the 1.5 MHz hfMAT-MI does not provide MNP distributions as 
detailed as the 2.25 MHz system, the high power (up to 25 kV) capability of this 
Figure 22. 1.5 MHz hfMAT-MI imaging phantom with MNPs. (A) An agar phantom with three 
cylindrical MNP inclusions having EMG 304 (ferrum concentration is 3.73 mg/mL). (B) The hfMAT-
MI image of the phantom in (A). (C) After euthanizing a mouse subject, 60 mg Fe/mL EMG 304
MNPs were injected into the brain through a 1-mm burr hole. (D) The distribution of MNPs inside
the mouse head reconstructed with 1.5 MHz ultrasound.  
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1.5 MHz system is seen to provide a relative high sensitivity (3.73 mg Fe/mL) and 
meanwhile shortened scanning duration. Still, it can be observed that Fig. 22B and 
D depict the nanoparticles with a better spatial resolution than those presented 
with the regular MAT (Figs. 17, 19, 20). Interestingly, although there would be 
unsurprisingly significant ultrasound signal attenuation due to the skull, the 
magneto-force induced ultrasound signal at 1.5 MHz can still be partially detected 
in order to have a rough estimation of the distribution of MNPs behind the skull; we 
can thus qualitatively know that the original signal strength would be remarkable. 
3.4.3 hfMAT for Epidermal Growth Factor Receptor (EGFR)-targeted MNPs 
With the regular MAT as its results being summarized in 3.4.1, the magnetic 
nanoparticles were local injected to the tumor protrusion for further imaging tests. 
Our goal for the magnetoacoustic imaging of MNPs is to test out whether or not 
we can probe the nanoparticles with MAT, in which the nanoparticles per se are 
specifically targeting to the growing tumor and injected without knowing the 
location of cancerous tissues. Although considered as highly demanded, this has 
been long believed as a grand challenge majorly because of the feasibility of 
fabricating such targeted MNPs. Dr. Panyam’s group in UMN have successfully 
synthesized a type of water-dispersible EGFR-targeted superparamagnetic iron 
oxide (SPIO) MNPs for inhalation to treat non-small cell lung cancer (NSCLC) [177], 
as the EGFR overexpression is observed to be phenomenal in NSCLC patients 
[178, 179]. With the help from his group, EGFR-targeted EMG 308 ferrofluid 
(ferrum concentration: 3.2 mg/mL) has been developed for pursuing this goal. 
Using the similar animal protocol mentioned in 2.3.3 and 2.3.4, after anesthetizing 
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the animal, this in vivo experiment injected the targeted MNPs to the nude mice 
subject through tail vein by 200 μL at least 40 minutes prior to the 1.5 hour-long 
hfMAT scanning. It is worth to note here that the static magnetic field has been 
removed from the hfMAT-MI setup in order to eliminate confounding signals by 
Lorentz force, i.e. the signal obtained from hfMAT can be all attributed to the 
presence of MNPs, given that the flux density magnitude of pulsed magnetic field 
is about 50 times weaker than that of the static one (Fig. 8c-f). The tiny ultrasound 
signals generated on the MNPs were harnessed to reconstruct the presence of 
nanoparticles, as shown in Fig. 23B. The dashed oval circles the suspected signals 
originating from the unilateral side of tumor protrusion. There might be retention of 
the targeted MNPs taking place at the cancerous tissue, although the generated 
signal is so weak to reach the detection sensitivity limit. Despite of the challenges, 
Figure 23. The first trial of magnetoacoustic imaging of EGFR-targeted MNPs. (A) The tumor-
bearing nude mice was injected with the EGFR-targeted SPIO nanoparticles through the tail vein.
(B) 1.5 MHz hfMAT-MI reconstructed signals show the residual MNPs in the tail and part of the
injected nanoparticles appear at the tail tip (indicated by red line arrows). The dashed oval circle
and the filled red arrow indicate suspected signals originating from the unilateral side of tumor
protrusion. (C) The line profile of the reconstructed signals along the white dashed line in (B). 
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this is indeed the first trial of using magnetoacoustic imaging to capture the 
presence of tumor-targeted nanoparticles. 
3.5 Discussion 
We applied magnetoacoustic tomography (MAT) and high-frequency MAT-
MI methods using a short pulsed magnetic field to image magnetic nanoparticles 
applied to prostate tumors in a mouse model. The preliminary in-vivo study shows 
that the images of the IONP present in the tumor are reconstructable. Further, we 
tested the strength of the MAT signal which is proportional to the dependence on 
the concentration of magnetic nanoparticles for a phantom with uniform z-
directional distribution of nanoparticles. The acoustic source creating the MAT 
pressure signal is the divergence of the magneto motive force. This is dominant 
along the z direction in the experimental setup over the object region and depends 
on the z distribution of the IONPs in this MAT setup. Therefore, to further obtain a 
quantitative map of the IONP distribution, this z-dependence of the acoustic source 
would have to be taken into account. This can be achieved by varying the z profile 
of the magnetic field and performing multiple measurements and combining them 
as used in multi excitation methods proposed in electrical properties imaging [44, 
180]. This could give a quantitative distribution which could be useful in designing 
therapeutic applications. 
The MAT signal from the IONPs is in the same frequency range as the 
applied RF pulsed field, matched to the ultrasound scanner being used to measure 
the signal for optimum signal recording. The ultrasound systems have a limited 
bandwidth around a center frequency governing the resolution of the image 
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reconstruction. The ultrasound resolution can be obtained, for the tomographic 
reconstruction method used in the current study, by estimating the point spread 
function of the imaging system. This is done by using a point source in Equation 
13, ∇ ⋅ Fm ( r ) = δ ( r ), and substituting the estimated pressure in Equation 14. 
This gives the reconstruction of a point source with this imaging system, which is 
an estimate of the imaging point spread function. The current ultrasound imaging 
system used in MAT imaging has a center frequency of 500 kHz leading to an 
imaging resolution better than 2 mm shown in previous resolution estimating 
experiments and simulations of the point spread function of the ultrasound system 
[159, 176]. The imaging depth of the MAT system is governed by the attenuation 
of the ultrasound wave travelling through tissue. Unlike ultrasound, the magnetic 
field in the low MHz range used in MAT method does not get attenuated by the 
tissue [45, 169]. The strength of the ultrasound wave decays exponentially: p(x) 
= p(0) exp(−αx), where x is the depth of the MAT source from the sensor, p(0), p(x) 
is strength of the signal at the source and sensor, α is the ultrasound attenuation 
coefficient. The attenuation coefficient α is around 1 dB/cm for most soft tissue at 
1 MHz frequency. In the current system the signal from the MNPs embedded in 
the tumors on the surface of the mouse leads to an imaging contrast of 5–7 times 
due to the improvement in SNR from the signal averaging from various 
measurement directions present in the image reconstruction method. 42 This 
imaging contrast is proportional to the strength of the signal which is obtained at 
the surface of the body of the mouse. Assuming an imaging contrast of 2 would be 
the limit of the imaging depth, with the exponential decay of the pressure wave, 
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this contrast would be obtained for an imaging depth of around 10 cm in soft tissue. 
The spatial distribution of the magnetic field generated in the MAT method is 
governed by the geometry of the coils [45, 169]. In the present study we use a 5 
cm diameter coil and the imaging region is located 2.5 cm from the coil surface. 
To obtain a similar strength magnetic field at a larger depth either a larger diameter 
coil or coil arrays could be used. 
In the current imaging setup, a single transducer scanning mechanically 
around the object is used for the data acquisition. For the data to image a tumor 
region with the tomographic method used, 50 min of scanning time is required (140° 
view angle). However, the use of ultrasound imaging arrays to acquire these data 
in parallel could significantly shorten this time. After this data acquisition, an 
ultrasound back-projection algorithm with built-in data filtering is used to 
reconstruct the acoustic source from IONPs. Thus, each of the presented 
tomographic images of the nanoparticles' spatial distributions can be produced 
less than 5 s by a computer with an Intel Core i7 processor. 
In the MAT method, though, we apply a very large magnetic field of around 
120 mT at ultrasound frequencies which can lead to induced electric fields in the 
sample to be around 550 V/m. This is comparable to the stimulating strength in 
transcranial magnetic stimulation (TMS). However, the total energy applied to the 
samples in MAT is much lower than TMS, as the MAT pulse duration is at the 
microsecond level instead of hundreds of microseconds in TMS. Additionally, the 
temperature rise due to a microsecond long pulse applied to the IONP at the 
concentration of EMG 308 is around the mK range [80], and also the pulse is 
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repeated at a slow repetition frequency under 50 Hz further dissipating the heat 
deposited leading to unsubstantial temperature rise in the object. Thus, the use of 
a short duration pulse reduces the amount of energy deposited in the tissue. 
The acoustic homogeneity assumption used in the theoretical derivation in 
this study restricts the proposed imaging method to primarily soft tissue imaging. 
The acoustic heterogeneity of soft tissue is less than 10%, and its effect can be 
negligible for those imaging techniques based on the acoustic measurements of 
induced ultrasound signals  [181, 182]. 
In these MAT-based in-vivo imaging studies we performed intratumoral 
injections to have efficient accumulation of the non-targeted superparamagnetic 
nanoparticles. These intratumoral injections lead to the uneven distribution of 
nanoparticles in the tumor. We have initiated the studies using tumor specific 
antibodies modifying the magnetic nanoparticles that would be applied 
systemically through blood; and on accumulation in the tumor, it would be imaged 
as a potential method for early detection of tumors for screening purposes. Also, 
superparamagnetic iron oxide nanoparticles are seen to have low cytotoxicity 
concerns [82] enabling them to be more suitable for cellular/molecular biomarkers 
in biomedical applications which could be a concern with contrast agents required 




Chapter 4. Non-Invasive Brain Imaging Perturbed by Low-
intensity tFUS 
4.1 Introduction 
In this chapter, by reversing the MAT-MI model, I will firstly introduce an 
intermediate study using focused ultrasound to stimulate and generate local 
electrical potentials in agar phantom and excised fresh brains in the existence of 
a static magnetic field. Subsequently, I will further summarize my work on using 
electrophysiological source imaging (ESI) to monitor global brain responses in vivo 
perturbed by low-intensity tFUS. 
Imaging brain activity is of utmost importance to understand the brain. 
Functional imaging modalities have been developed to understand the brain’s 
mechanisms of action, including fMRI, electroencephalography (EEG), 
magnetoencephalography (MEG), positron emission tomography (PET), etc. 
While these imaging modalities are noninvasive in nature and have been used 
widely to study human brain functions and dysfunctions, they are limited in either 
spatial resolution (such as EEG or MEG) or temporal resolution (such as fMRI and 
PET). EEG/MEG offers high temporal resolutions capturing brain dynamics, yet 
has limited spatial resolution to image brain activity due to the head volume 
conduction effect. fMRI is widely utilized for neuroscience research. However, the 
present resolution of 3 Tesla fMRI typically used for cognitive neuroscience studies 
and clinical applications is few millimeter (mm) spatially (voxel size) and in the 
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order of seconds temporally. Such temporal resolution is far below the neural 
activation in which action potentials are firing, in the order of one millisecond. 
Perturbation-based neuroimaging is a novel pathway for neuroimaging by 
combining neuromodulation with the functional neuroimaging modalities. Current 
electric and electro-magnetic non-invasive neuromodulation approaches like 
transcranial magnetic stimulation (TMS) and transcranial direct current stimulation 
(tDCS) have poor spatial resolution, suffer from a depth-focality tradeoff and 
experience significant attenuation at depth, thus making them inappropriate to 
effectively stimulate specific neural circuits. Transcranial focused ultrasound (tFUS) 
is a new and promising non-surgical, low-energy technique for inducing transient 
plasticity with high spatial resolution, adjustable focus and low soft-tissue 
attenuation. Despite the unclear mechanism, there are mounting evidences that 
ultrasound can interact with neural tissue. Ultrasound has been proved to 
noninvasively stimulate the animals’ hippocampus and motor cortex, and even 
disrupt seizure activity induced by chemicals in animal models. tFUS has recently 
shown its capability to be a safe, effective, and highly spatial-selective 
neuromodulation method in humans. Therefore, an integration of EEG and tFUS 
would identify a portable, noninvasive perturbation-based neuroimaging modality 
having high spatiotemporal resolution. 
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4.2 Characterization of the Lorentz Current Induced by Acoustic Radiation 
Force (ARF) 
4.2.1 Theory 
Ultrasound technique has attracted great attention and been used to 
mediate the stimulation process. Instead of passively detecting ultrasound waves 
from Lorentz force and/or magneto-motive force, in our proposed non-invasive 
stimulation scheme, an active focused ultrasound beam is transmitted to vibrate a 
local volume of a conductive object with the ARF. With the existence of an external 
magnetic field, a corresponding Lorentz current 𝑱𝑳 𝒓,  𝑡  is thus induced at the focal 
spot of the ultrasound beam as described as in Equation 16 [23, 183]: 
𝑱𝑳 𝒓, 𝑡  𝜎 𝒓  𝑩𝒛 𝒗 𝒓, 𝑡                                   (16) 
in which 𝜎 𝒓  is the tissue electrical conductivity, and the ultrasound-induced 
vibration has a velocity v 𝒓, 𝑡  within a constant magnetic field 𝑩𝒛. Our hypothesis 
is that using acoustic radiation pressure (ARP) in a focused way can increase the 
mechanical motion of the vibrated tissue, thus improving the stimulation efficacy. 
4.2.2 Materials and Methods 
In this present study, we have tested this ultrasound-induced directional 
Lorentz-current stimulation in saline gel phantoms with dual mode ultrasound array 
(DMUA) [184, 185] in a collaboration with Dr. Ebbini’s lab at UMN. The dual-mode 
ultrasound array consists of 2x32 elements operated at a center frequency of 3.2 
MHz with a concave spherical radius of 40 mm. The F number is 0.86 given its 
small focal length relative to the big effective ultrasound aperture. The DMUA is 
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able to achieve a small focal spot, with a -6 dB contour at 1.6 mm in axial direction, 
0.25 mm in lateral direction (Fig. 24a). 
To effectively receive the ultrasound radiation pressure, a certain 
concentration of cellulose is introduced as ultrasound scatterer in the preparation 
of the phantom, thus the phantom was imaged as Fig. 24b. To determine the 
induced current, a pair of unipolar needle electrodes and electric potential 
measurement are used, and the ultrasound image shows the distance between 
the two electrodes is about 4 mm (Fig. 24c). Fig. 25 shows a conceptual diagram 
of generating and recording the focal Lorentz-current in phantom tissues. The 
Figure 24. DMUA imaging performances. (a) The spatial resolution characterization (adapted
from Casper et al. 2013). (b)  Ultrasound imaging by the DMUA of a cellulose phantom. (c) An
ultrasound image of a phantom inserted with two needle electrodes presented as two white spots. 
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DMUA is programed to transmit customized ultrasound waveforms, which are 
amplitude-modulated with low-frequency envelope, e.g. < 100 Hz. 
Fig. 26 shows the sonication temporal profiles, ARF-induced electrical 
potentials and their spectral power density. The estimated Lorentz current density 
is 4 μA/cm2 at the ultrasound focal region (comparing with 83 μA/cm2 used in tACS 
by [95]). It can be observed that the spectral contents of the induced Lorentz 






Figure 25. Diagram of Lorentz-current stimulation and recording system. 
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Furthermore, I characterized the spatial specificities of the induced Lorentz 
current in freshly excised rat brains after euthanizing the rat subjects. As shown in 
Fig. 27a, the electrode’s pair is moving axially following the arrow in the phantom 
(in blue color), and from the spectral power densities, it can be seen that the axial 
spatial specificity (-3 dB) is about 2.2 mm (Fig. 27b). Next, one of the electrodes is 
step-wisely moving away from the fixed electrode (Fig. 27c), and it thus can be 
found that the lateral power density decreasing rate is about 6 dB/Hz per millimeter 
(Fig. 27d). 
 
   
 
Figure 26. The ultrasound temporal profile and the recorded electrical signals with their




4.2.3 Preliminary Results 
Following the characterization on excised brain samples, I also tested the 
Lorentz current neuromodulation on in vivo rat model with stimulated by a single-
element transducer and recorded by concurrent 24-channel scalp EEG recordings 
(Fig. 28a). The protocols on sonication setup, in vivo rat model preparation, and 
electrophysiological signal detection and preprocessing will be further described in 
section 4.3. The 50 ms sonication (Fig. 28b) consists of repetitions of the single 
pulses with each lasting about 70 μs (Fig. 28c), and the peak-to-peak ultrasound 
pressure measured by a needle hydrophone is about 80 kPa. The butterfly plots 
Figure 27. The spatial specificity of the Lorentz current characterized in the axial direction
(a-b), and in the lateral direction (c-d). 
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stack those original EEG signals together while the mean global field power 
(MGFP) demonstrate the distinct features of electrophysiological signals 
comparing the baseline condition (only with static magnetic field) to the tFUS 
Figure 28. In vivo test of Lorentz-current brain stimulation. (a) In vivo anesthetized rat 
experiment setup. (b-c) The temporal profiles of transmitted ultrasound by a single-element 
transducer. (c) is a zoom-in profile of the red-boxed region in (b) showing the single ultrasound
pulses. (d) 24-channel EEG butterfly plots for the baseline and tFUS. (e) Mean global field power
of EEG for the baseline and tFUS. The green bars in (d) and (e) indicate the sonication period. 
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condition (combining the ultrasound with the magnetic field) (Fig. 28d-e). Notably, 
the time-locked brain responses in both plots may indicate the neural 
neuromodulatory effects potentially induced by the Lorentz current. 
Figure 29. The tFUS perturbation-based brain mapping. (a) The butterfly and MGFP plots 
capture a global response to the 50 ms Lorentz current stimulation. (b) Time frames of topographic 
voltage map spanning from at an initial time (2 ms) to a post-stimulus time (103) ms. Each map is 
corresponding to the time line indicated with same color. The grey crosses in these maps indicate 
the sonication site. (c) The EEG electrodes’ locations are mapped with micro-CT images. 
88 
 
Moreover, Fig. 29b depicts a series of topographic voltage maps at 2, 20, 43, 58, 
and 103 ms relative to time of the sonication onset (0 ms). It can be observed that 
the initial focal activation aligns the sonication site; however, such an activation 
has its dynamics of rapidly propagating to other brain areas. Using the scalp 
electrophysiological recordings empower a high temporal resolution to potentially 
identify the tFUS-evoked brain dynamics. To obtain precise topo maps, the 
locations of EEG electrodes are estimated with micro-CT images acquired by a 
Siemens Inveon preclinical microPET/CT (University Imaging Center, UMN). 
Still, there are two major issues of this “Lorentz current stimulation” study. 
One issue is that the topography is not able to present high spatial resolution; and 
the other one is that the tFUS per se may also lead to brain activation, which means 
that the observed brain activations (Fig. 29a) may be attributed to the mechanical 
effects conferred by the tFUS. For these reasons, by collaborating with my lab 
colleague, Abbas Sohrabpour for further investigations. 
4.3 Non-invasive EEG Source Imaging of Brain Activations by Low-intensity 
tFUS 
There is an unanswered question whether low-intensity tFUS (much lower 
than FDA’s regulations) can induce EEG responses over the scalp or not. We 
report our experimental study to noninvasively detect and localize brain activity 
from scalp EEG following low-intensity tFUS in an in vivo rat model. In this section, 
I will review my collaborative work on using EEG-based source imaging to globally 
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map the tFUS-induced brain responses with high temporal resolution and 
improved spatial definition. 
4.3.1 Sonication Setup 
tFUS pulses were produced in a burst mode by a single-element focused 
ultrasound transducer (V389, Olympus, USA) and were employed to perturb the 
intact rat brain in anesthesia, as shown in Fig. 30. This ultrasound transducer has 
a diameter of 38.1 mm, a center frequency of 500 kHz, a -6 dB bandwidth of 300-
690 kHz and a nominal focal distance of 55 mm. The transducer is controlled by 
two function generators (33220A, Keysight Technologies, USA) that manage the 
time sequence of ultrasonic output, so as to produce a specified time burst of 
pulses with 2 kHz pulse repetition frequency (PRF) in 3 s inter-sonication intervals. 
Such ultrasound temporal protocol was developed following Tufail et al. [186, 187] 
and Yoo et al. [99, 102]. Instead of tone burst mode (i.e. tens of cycles in each 
pulse duration) used in their experiments, in this present study we used the single-
pulse burst mode as shown in Fig.30 to significantly reduce the Ispta and Isppa. These 
pulses triggered an ultrasonic pulser unit (5077PR, Olympus NDT, USA), which 
controlled the voltage amplitudes fed into the transducer. To guide the ultrasound 
energy onto a certain brain location, a customized conical ultrasound collimator 
was fabricated using a polypropylene funnel and a polytetrafluoroethylene 
cylindrical tube, and was then filled with ultrasound coupling gel (Aquasonic 100 
Ultrasound Transmission Gel, Parker Laboratories, USA). This collimator had an 
inner diameter of 1.7 mm at its tip, and its total length equaled the focal distance 
of the transducer. The directed acoustic intensities (Ispta: 0.1-0.6 mW/cm2, Isppa: 
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0.74-4.6 mW/cm2, spatial-peak temporal-peak intensity Isptp: 38-252 mW/cm2, 
corresponding to spatial peak rarefactional pressure Pr amplitude of 18.3-45.9 kPa) 
transported through the collimator were then measured using a calibrated 
hydrophone (HNR500, Onda, USA) placed behind a piece of freshly excised 
Wistar rat skull. To measure such ultra-low intensity, a calibrated, broadband 
hydrophone preamplifier (AH-2010-025, Onda, USA) was also employed. Notably, 
the administered ultrasound intensities were far less than the safety limit, i.e. Ispta 
of 720 mW/cm2 and Isppa of 190 W/cm2, used in ultrasound diagnostic imaging 
systems, set forth by the U.S. Food and Drug Administration (FDA) [188, 189]. By 
further measuring the acoustic pressure directly at the tip of the collimator, the 
ultrasound insertion loss as calculated for the pressure, was approximately -14 dB 
across the sites on the skull where the transducer would be placed in our 
Figure 30. The sonication waveforms used in the in vivo experiment. (© 2016 IEEE) 
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experiment. The collimator, the skull sample and the needle hydrophone were 
aligned using a 3-axis positioning stage. This positioning stage was controlled by 
a stepper motor system, and was also used to aim the ultrasound transducer and 
collimator to a specific scalp region during the in vivo experiments. 
4.3.2 In vivo Rat Model 
The Wistar rat was chosen for the in vivo study mainly due to its relatively 
big cranial size and thinner skull among the rat species. Three one-year-old rat 
subjects were used, and each was anesthetized using katamine/xylazine mixture 
(75 mg/kg and 10 mg/kg respectively) with certain dosage determined by both the 
rat’s weight and the anesthetic duration (2-3 hours). The hair over the rat’s scalp, 
the nape, hind limbs and caudal regions were carefully removed using an electric 
hair trimmer and a hair remover cream lotion, to expose the skin. After the exposed 
skin was further degreased using alcoholic pads, and the impedance was lowered 
using skin prep gel, EEG and ECG electrodes were then attached to the treated 
skin regions, accordingly. During the experiment, a rectal thermometer and a 
Parameters SI 1 SI 2 SI 3 
Ispta (mW/cm2) 0.1 0.2 0.6 
Isppa (mW/cm2) 0.7 1.4 4.6 
Isptp (mW/cm2) 38 83 252 
Pr (kPa) 18.3 27.9 45.9 
Pp (kPa) a 16.1 22.8 42.8 
a Pp: spatial-peak positive pressure amplitude. 
Table 1. Ultrasound Parameters for Three Sonication Intensities (SI) (© 2016 IEEE) 
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heating lamp were used to monitor and maintain the rat body temperature. This 
experiment protocol was approved by the University of Minnesota Institutional 
Animal Care and Use Committee. 
4.3.3 Electrophysiological Signal Detection and Preprocessing 
All the electrophysiological signals were acquired, amplified, filtered and 
digitized using a multi-channel NeuroScan system (Synamps 2, Compumedics, 
USA) with a sampling rate of 1 kHz. The EEG was simultaneously recorded and 
synchronized with the ultrasound system so as to know exactly when the 
sonication pulses were administered. During the data acquisition, the bandpass 
filters with respective cutoff frequencies were applied to EEG, and ECG channels. 
8-channel EEG recordings were used to assess the effect of sonication intensity 
on brain activation, and 16-channel EEG recordings were used to measure the 
spatiotemporal distribution of the brain electrical activity as induced by tFUS. EEG 
data were further bandpass filtered and preprocessed for source imaging analysis. 
The epochs of ultrasonic stimulations were aligned by using the event markers 
transmitted by the function generator in the sonication setup. Additionally, the 
short-time Fourier transform (STFT) of the mean global field power (MGFP) of the 
averaged ERP was also plotted using a Hamming window of length 32 ms and 
overlap of 4 ms.  
A sham condition was designed by removing the ultrasound collimator and 
turning the transducer away from the rat scalp while transmitting ultrasound pulses. 
In order to only image the brain activity due to sonication and to reduce the effect 
of common activity perceived in the sham condition, the common components of 
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activity observed in the sham condition were removed from the ERP signals prior 
to source imaging. Auditory pathways may be activated during the ultrasound 
pulse generation, as animals like rat are capable of hearing frequency ranges 
much higher than human beings [190]. This was achieved by performing the 
principal component analysis (PCA) and identifying components demonstrating a 
high correlation with the sham components. Independent component analysis (ICA) 
[191] can be used to perform this analysis, as well. ICA is a promising method 
when dealing with artefacts, since such interferences are independent of the brain 
activity and ICA is efficient in detecting and removing those signals. Mainly the 
interferences can be roughly categorized as physiological artefacts such as eye 
movement, muscle contraction, and electromagnetic interferences from 
stimulation or 60 Hz power-line noise. In our experiment the animals were 
anesthetized, the aforementioned physiological artefacts were minimal and absent 
after averaging. Since ultrasound stimulation was administered, no 
electromagnetic interference was introduced by stimulation and power-line noise 
was removed with a 60-Hz notch filter. The PCA [192], however, determines main 
components in the data based on their strength (signal energy which is related to 
signal’s second norm). Thus, we could compare strong components present in the 
two conditions, i.e. sham vs. stimulation, to reject common components which are 
related to background brain processes (not artefacts). For example, auditory 
pathways may be activated during the ultrasound pulse generation, as animals like 
rats are capable of hearing frequency ranges much higher than human beings. In 
this sense, ICA might not add an extra value for component analysis, thus PCA 
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and ICA could be used interchangeably and both analyses actually show many 
similar components. 
4.3.4 EEG Source Imaging 
We used a publicly available Wistar rat MRI atlas 
(http://www.idac.tohoku.ac.jp/bir/en/db/rb/101028.html) to build a generic 
boundary element method (BEM) model of the rat head, as individual head MRI 
was not available at the time [193]. The BEM head model consisted of three layers 
of tissue, namely, the skin, the skull and the brain with conductivities of 0.33 S/m, 
0.0165 S/m and 0.33 S/m, respectively [194-196]. The minimum norm (MN) 
algorithm [197] was used to solve the inverse problem. As mentioned previously 
using PCA, the components of the EEG signal that were highly correlated with the 
EEG recorded during the sham condition were removed from the EEG prior to 
source analysis. The source imaging was performed for the duration of the 
sonication and after cessation of stimulation, for about several hundreds of 
milliseconds. 
4.3.5 Statistical Testing  
In order to test the significance of the results when comparing ERP signals 
to the sham condition, we performed statistical testing to determine time intervals 
at which the ERP signals and the sham condition were significantly different 
(p<0.025). We performed a paired t-test to this end. The data recorded at different 
channels of the EEG were treated as samples drawn from the two conditions 
(sham vs. ERP induced by sonication). The amplitudes of the signal in the two 
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conditions were compared over time to find time intervals at which a significance 
of (p<0.025) was achieved [97, 106, 198]. 
4.3.6 Results 
Fig. 31 shows the 8-channel scalp EEG recordings of the tFUS-evoked 
brain activities in a rat from three ultrasound intensities (as listed in Table I) used  
Figure 31. tFUS-evoked brain activities induced by three sonication intensities (as shown
in Table I) recorded by 8-channel scalp EEG. (a) Butterfly plots of EEG waveforms, (b)
ultrasound pressure-time plots for each sonication intensity, (c) EEG MGFP plots, and (d) a bar





Figure 32. Averages of ultrasound-induced electrical potentials recorded with a 16-channel
EEG. These potentials are in response to (a) 5 ms, (b) 50 ms, and (c) 200 ms sonication conditions
in a top-view of the rat head. The channels indicated by the orange squares, i.e. electrode #9, #12,
and #16 are shown at a higher gain in (d), in which the EEG recordings with three sonication
durations are plotted for each electrode. The vertical dotted lines demonstrate the time points (17,
35, 95 and 294 ms) of interests at which the peaks of neural activity locate, and those average
values and standard deviations are depicted in (e). The t-tests with p values indicate significant
effects of sonication durations in each electrode as presented in (e). (© 2016 IEEE) 
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to sonicate the targeted right anterior cortex. These intensities are due to three 
different excitation voltages that drive the transducer. After averaging across 300 
trials, the results are illustrated in the time course (from -200 to 600 ms, 0 ms 
indicates the onset of the 200-ms sonication) both with butterfly plots and MGFP 
plots. Fig. 31 indicates that even when a low-intensity sonication (Ispta: 0.1 mW/cm2, 
Isppa: 0.7 mW/cm2) is administered with the applied ultrasound pressure recorded 
in Fig. 2(b), the rat brain shows an observable time-locked activation as 
perceivable in the EEG. When increasing the input ultrasound intensities, the 
recorded EEG shows increasing response amplitudes and extended activations as 
depicted in Figs. 31(a) and (c). If one takes the time integral of the MGFP within 
the sonication duration of 200 ms, the results demonstrate an increasing trend 
shown in Fig. 31(d). These integral values are calculated using trapezoidal 
integration method with an integration step of 1 ms. 
Fig. 32 shows 16-channel scalp ERPs averaged from 600 trials of another 
rat subject. The channels indicated by the orange squares, i.e. electrode #9, #12, 
and #16 are further magnified in Fig. 32(d), in which the neural recording under 
three sonication durations are plotted for each electrode. Within sonication period, 
all those three conditions use acoustic intensity Ispta of 0.6 mW/cm2 (Isppa: 4.6 
mW/cm2, Isptp: 252 mW/cm2) when the tFUS wave reaches the skull covering the 
targeted cortical region. The vertical dotted lines in Fig. 32(d) show the time points 
of interest at the extrema of neural activity time course. Fig. 32(e) depicts the 
averaged signal values and standard deviations at the four time points (i.e. 17, 35, 
95 and 294 ms) read from the three individual EEG electrodes (indicated by orange 
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squares in Fig. 32(a)(b)(c)). Significant differences exist at 294 ms among three 
sonication durations from recorded signals by three electrodes. Electrodes #12 
and #16 also present significant differences at 35 ms in the signal profiles by the 
5-ms and 200-ms sonication durations.  
Figure 33. Comparing the brain activity during sonication with the sham condition. (a) The 
MGFP is depicted for the two conditions, namely the 200 ms sonication (Ispta: 0.6 mW/cm2, 
Isppa: 4.6 mW/cm2, Isptp: 252 mW/cm2) and sham. The green bar indicates the duration for which
the tFUS was administered (200 ms) and the gray bars indicate the time intervals during which
the amplitude of the EEG signal was statistically different for the two conditions (p<0.025). (b)
The short-time Fourier transform of the MGFP of the two conditions is calculated and compared
against each other. (© 2016 IEEE) 
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Inevitably, the audible sound from tFUS may also result in auditory evoked 
potentials. In the in vivo experiment, during the sham condition, the transducer 
keeps transmitting ultrasound as in the stimulation session, using 200 ms 
sonication, while the transducer is flipped to point away from the animal. Fig. 33(a) 
depicts the MGFP values of the 16-channel EEG recordings of the sham 
ultrasound condition (red), and its comparison to the 200 ms tFUS condition (black). 
The gray vertical bars at 8-19 ms, 33-109 ms, and 267-311 ms indicate significant 
differences (paired t-test, p<0.025) in the amplitude of evoked neural signals 
between the sham and the transcranial sonication conditions. Fig. 33(b) shows the 
time-frequency plots depicting the spectral contents in α (7-12 Hz), β (13-30 Hz), 
and lower γ (31-55 Hz) frequency bands of the elicited brain activity after the onset 
(dashed vertical lines) of the sonication. Compared to the sham condition, we also 
found significant differences existing within each frequency band during 0-100 ms 
and 200-250 ms produced by the 200 ms tFUS. Hence, based on the analyses of 
global field power and spectral power, the tFUS-evoked brain activities can be 
distinguished from the sham condition. 
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Signals from the sham condition have been subtracted from the recordings 
with the tFUS condition. Solving the inverse problem using the MN method, the 
EEG source images were obtained to estimate the spatial location of the 
Figure 34. ESI neuroimaging of brain activity induced by the 200 ms low-intensity tFUS 
stimulation at the right anterior cortex in a rat. In this experiment, the tFUS transducer was
placed over the right hemisphere as indicated in the 3D model (a), and the schematic diagram (b),
where the cross depicts the placement of ultrasound transducer. The MGFP of the recorded EEG
signal (c), in which the black solid line indicates the onset of sonication, and the blue, red and purple
dashed lines represent the temporal instances of relative peaks in the MGFP (21 ms, 50 ms, and
109 ms). The topographical voltage maps (d) and source images (e) of these instances are depicted
correspondingly. (© 2016 IEEE) 
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ultrasound perturbation and its induced brain activation. In the presented ESI 
results, we found that the estimated source covered cortical regions including the 
targeted region of the ultrasound beam. Further, a series of EEG topographic 
voltage maps and source images at several time points of relative signal peaks 
(21, 50, 109 ms) in the MGFP plot are depicted in Fig. 34(c), (d) and (e), while the 
relative locations of the rat brain, the cranial bone, the ultrasound incidence, and 
the EEG electrodes are shown in Fig. 34(a) and (b), respectively. From the 
presented source images (Fig. 34(e)), the location of the initial activation (21 ms) 
aligns with the ultrasound targeting region, and this activation soon propagates to 
the surrounding cortical regions (50 ms). Because the tFUS keeps depositing 
mechanical energy during the sonication period, the brain activation source stays 
at the right anterior cortical region (50 and 109 ms), and meanwhile several other 
cortical areas become active successively. 
When the same ultrasound beam is directed at another anterior cortical 
region which is more lateral, the ultrasound intensity reaching the brain tissue 
would be even less due to an increasing skull thickness of the rat cranium. 
Therefore, the amplitudes decrease as observed in the topographic voltage maps 
and the EEG source imaging results (Fig. 35(d) and (e)). From these results, it is 
shown once more that the initiation region of cortical activation (17 ms) follows the 
ultrasound incidence site, and later at 68 ms, this source activation propagates to 
other brain regions while the initiation region remains being activated by the 
ongoing ultrasound stimulation. 
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A third rat was also studied using the same sonication condition as 
harnessed in Figs. 34-35, whereas ultrasound incidence site was changed to the 
Figure 35. ESI neuroimaging of brain activity induced by the 200 ms low-intensity tFUS 
stimulation at the left anterior cortex of a rat. In this experiment, the tFUS transducer was placed
over the left hemisphere as indicated in the 3D model (a) and the schematic diagram (b), where the
cross depicts the placement of ultrasound transducer. The MGFP of the recorded EEG signal (c),
in which the black solid line indicated the onset of sonication, and the blue and red dashed lines
points to the temporal instances of the relative peaks in the MGFP (17 ms, and 68 ms). The
topographical voltage maps (d) and source images (e) of these instances are depicted
correspondingly. (© 2016 IEEE) 
103 
 
location of electrode #9 as mapped in Fig. 32(a). Similar ESI results were observed 
in this case comparable to other two animals (data not shown). 
4.4 Discussion 
We have conducted an experimental investigation to demonstrate the 
feasibility of noninvasively recording brain electrical activity as induced by low-
intensity tFUS in an in vivo animal model. We have also demonstrated, for the first 
time, that it is possible to image brain electrical activity from noninvasive scalp 
EEG recordings following tFUS perturbation. Our results suggest that ESI may 
become a useful tool to derive biomarkers to quantify tFUS effects and guide its 
use for neuromodulation. Such noninvasive biomarker, while obtained in real time, 
may offer important insights to optimize tFUS stimulation parameters and make 
tFUS a closed-loop neuromodulation modality. 
Our work also suggests using tFUS as an important guide for perturbation 
based neuroimaging. In perturbation based neuroimaging [85], external energy is 
applied to alter the neural information processing; the spatio-temporal activation 
patterns as altered due to such perturbations, can then be used to identify and 
delineate the mechanisms of neural activation and pathology. For this purpose, it 
is important to use low intensity neuromodulation so the injected energy will only 
present perturbations to avoid global and wide-spread effects.  
In our work, using a single-element focused ultrasound transducer with a 
collimator, we introduced the low-intensity tFUS (Ispta as low as 0.1 mW/cm2, and 
Isppa as low as 0.7 mW/cm2) as a brain perturbation tool and demonstrated the 
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capability of noninvasively recording electrophysiological responses of the brain 
following such low-intensity tFUS perturbation. By stimulating multiple sites and 
localizing the initiation site of the induced activity, our results confirmed such local 
activation can be noninvasively recorded and localized to the target site 
(corresponding to tFUS beam) by means of ESI. 
Considering the different skull thicknesses in various in vivo animal models 
or human subjects, one may need to compare the ultrasound intensities at the 
brain tissue (as opposed to ultrasound pressure at the scalp). In our in vivo rat 
experiment for tFUS-ESI, the applied Ispta (0.1-0.6 mW/cm2) is much lower than the 
lowest ultrasound spatial-peak temporal-average intensity (13.5±3.8 mW/cm2) 
ever reported in the past in vivo studies [101], to the best of our knowledge. For 
the neuroimaging purpose, such ultra-low intensity tFUS shall not damage the 
brain, but is still able to perturb the brain network. The present experiment has 
identified a low but effective tFUS intensity for EEG source imaging. Additionally, 
the ultrasound spatial-peak temporal-average intensity of less than 1 mW/cm2 (at 
the tip of collimator) ensures the non-invasive merit of tFUS (such level of 
stimulation did not induce other physiological activities such as leg movement, as 
the EMG did not show any detectable signal at both hind limbs). However, these 
parameters (at the tip of collimator and at the cortex) would need to be modified 
and scaled up, if to be used for human experiments. 
In our experiment, the fundamental ultrasound frequency used was 500 kHz, 
which may not be an optimal choice in terms of eliciting behavioral changes and 
neuromodulation. Some previous studies aiming to study effective ultrasound 
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parameters, to maximize sensorimotor responses in rats, reported that frequencies 
lower than 500 kHz were more effective in eliciting stronger EMG responses [129]. 
However, as lower frequencies lead to poorer ultrasound spatial specificity, a 
trade-off between the stimulating efficiency and spatial focality exists. Further 
investigation on effective frequencies needs to be done on an application-specific 
manner, as effective frequencies that elicit maximal behavioral responses, might 
be different for different networks in the brain. 
Our results, in general, support the hypothesis that tFUS-induced brain 
activity is generated from the point of cortex targeted by the ultrasound beam and 
propagates to surrounding tissue. Since the ultrasound transducer was not 
targeted at a specific location of cortex, and low intensity ultrasound (Ispta<1 
mW/cm2) was used in the in vivo rat experiment, no behavioral change was 
observed. Our results indicate a focus of activity forming under the ultrasound 
collimator on the cortex and its later propagation to nearby tissue. This is the first 
evidence of ultrasound-induced electrical activity captured non-invasively by 
dynamic EEG source imaging in a living system, to the best of our knowledge.  
While tFUS has been used in recent years to modulate and study the brain 
[97, 103, 106, 187] the neural effect induced by tFUS remains unclear [199, 200]. 
Use of ESI represents an opportunity to delineate the mechanism of tFUS by 
noninvasively mapping the spatio-temporal patterns of brain activation induced by 
tFUS. The specificity of tFUS and its ability to form concentrated foci, makes the 
combination of tFUS and ESI an ideal tool for noninvasively studying the brain. 
Using ESI to monitor the effects of tFUS stimulation can help not only in 
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determining the nature of neuromodulation therapies performed by ultrasound, but 
also to be used to study normal brain networks by exciting or inhibiting different 
brain locations [99], i.e. network nodes. Another impact of using ESI technique in 
ultrasound neuromodulation is that ESI is able to non-invasively document the 
targeted brain region by the transducer, which is considered as one of the 
challenges for ultrasound neuromodulation research.  
Ultrasound has also been used to treat pathological brain conditions. An 
early study by Manlapaz et al. [201] on a feline model provided experimental 
evidence as to the efficacy of ultrasound-induced attenuation of seizure activity 
and consequently decreased morbidity. A relatively high acoustic intensity of 840 
W/cm2 with a fundamental acoustic frequency of 2.7 MHz was used in the 
aforementioned study. More recently Min et al. [202] reported on a rat model 
having pentylenetetrazol-induced epileptic activity; the sonication (Ispta: 130 
mW/cm2) was shown to be successful in suppressing the occurrence of epileptic 
EEG bursts as observed in subdermal two-channel EEG recordings. These in vivo 
studies show the value of tFUS as a neuromodulation tool. Combined with ESI, the 
target to be stimulated by tFUS can be determined from electrophysiological 
recordings, thus allowing precision neuromodulation by assessing the tFUS effects. 
After tFUS is administered, the pathological activity, e.g. seizure, can be monitored 
by ESI to study the prognosis of stimulation and treatment efficacy.  
While the EEG was used to record and image brain activity as induced by 
tFUS in the present study, it is anticipated that one can use 
magnetoencephalography (MEG) [30] to record and image brain activity induced 
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by tFUS. Such demonstration shall be interesting for further investigation, and the 
present results indicate such possibility [1]. 
4.5 tFUS-ESI on Human Subject: A Pilot Study 
One of the most attractive advantages of tFUS is the non-invasiveness. 
Thus, to fully harness such merit for human applications, the non-invasive brain 
mapping approach, ESI is the one that has great promise working seamlessly with 
tFUS. The outstanding compatibility in a natural setting will facilitate the tFUS-ESI 
to become an effective combination for a translational use on humans. In a 
collaborative research experiment at Dr. Wynn Legon’s lab, we tested the tFUS-
ESI framework on a human subject. Following the similar protocol of experiment 
setup as reported in [97] without median nerve stimulation. As demonstrated in Fig. 
36, a single-element US transducer was placed over the motor cortex and 500 
Figure 36. tFUS stimulation in human (left upper) and ESI mapping of tFUS induced brain
activity (left bottom). The brain model is reconstructed from 3 Tesla MR images of the subject.
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pulses (pulse duration: 360 μs, PRF: 1 kHz) are transmitted at Isppa of 15.04 W/cm2 
with 500 kHz central frequency (upper left) while the multi-channel EEG is being 
recorded simultaneously. The sonication interval is generated randomly between 
6-10 s. The hand nub of the motor cortex is located using TMS stimulations and 
EMG monitoring, to detect index finger movement. Once the EEG is epoched and 
averaged around the tFUS stimulation instances, evoked potentials can be 
detected (lower right). The transducer was turned 180 degrees facing away from 
the scalp, and the stimulations were applied for the sham condition. No evoked 
potentials are observed (upper right). ESI imaging was performed, and the 
activated cortical area is localized to the hand nub of the pre-central gyrus (lower 
left). This promising preliminary human result demonstrates the merits and 
feasibility of the proposed ESI-tFUS as applied to human neuroscience. And in the 
meanwhile, real-time ESI may become an effective tool to non-invasively monitor 
the brain responses to the deposited ultrasound energy, which is deemed to lead 





Chapter 5. Towards the Mechanism of Ultrasound 
Neuromodulation 
5.1 Introduction 
 In concert with efforts pursuing agent-dependent enhancement of 
ultrasound modulation specificity, exploring ultrasound’s intrinsic cell-type 
selectivity may pave the way for the translation of tFUS as an effective non-
invasive modulation tool for brain stimulation and elucidating neural mechanisms. 
A unifying theoretical framework was formulated in order to map the acoustic 
parameters that lead to neuronal activation/suppression effects through cortical 
stimulation results based on their neuronal intramembrane cavitation excitation 
(NICE) model [203, 204]. While further validations are necessary, certain cell-type-
selective effects are predicted by this model when T-type calcium channels, 
existing in both cardiac and central nervous systems, are added in the neuronal 
modeling [203]. Inspired by this work and the increasing number of studies 
demonstrating ion channel dynamics as the mechanism of tFUS stimulation [199, 
205, 206], we investigate the cell-type dependent effects of tFUS stimulation 
through extracellular recordings in in vivo rodent brains. We hypothesize that, if 
the type and relative distribution of ion channels play a major role in tFUS 
mechanism of activating neurons, different neuronal types will have a distinct 
response profile to tFUS. 
As a common research method, intracranial electrophysiological recordings 
have been used to reveal the vivid neural activities [207]. To test our hypotheses, 
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we explored the effects of tFUS on single neuron spiking activity through multi-
channel electrical recordings, such as local field potentials (LFPs) and multiunit 
activities (MUAs), with high spatio-temporal resolution and measurement fidelity in 
in vivo anesthetized rodent models. 
5.2 Materials and Methods 
5.2.1 Experimental Model and Subject Details  
Rat Subjects: Wistar outbred male rats (Hsd:WI, Envigo, USA) were used 
as subjects, and all rat studies were approved by the Institutional Animal Care and 
Use Committee at University of Minnesota in accordance with US National 
Institutes of Health guidelines. 
Transgenic Mouse Subjects: Transgenic mice models are purchased from 
The Jackson Laboratory and bred to achieve the desired strains. CaMKIIa-ChR2 
mice are crossed between a T29-1 parent expressing calcium/calmodulin-
dependent protein kinase II alpha (CaMKIIa) promoter driving Cre recombinase 
expression, and an Ai32 parent, expressing channelrhodopsin-2/EYFP fusion 
protein following exposure to Cre recombinase. A genetically positive offspring co-
expressing ChR2 in CaMKIIa neurons are identified via tail snip DNA testing using 
YFP as a probe. PV-ChR2 mice are crossed between a PV-Cre parent expressing 
Cre recombinase in parvalbumin-expressing neurons and an Ai32 parent. A 
genetically positive offspring co-expressing ChR2 in PV neurons are identified via 
fluorescent protein visualization goggles (BLS, Budapest, Hungary). The 
procedures are reviewed and approved by the Institutional Animal Care and Use 
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Committee at the University of Minnesota in accordance with US National Institutes 
of Health guidelines. 
5.2.2 tFUS Setup and Parameter Selection 
Single element focused transducers were used for tFUS stimulation. 
Transducer diameter 28.5 mm, ultrasound fundamental frequency (UFF) 0.5 MHz, 
-6 dB bandwidth 300-690 kHz, a nominal focal distance of 38 mm. (V391-SU-
F1.5IN-PTF, Olympus Scientific Solutions Americas, Inc., USA). Collimators were 
3D printed with VeroClear material to match the focal length of the transducer and 
the animal model, the outlet of the angled collimator for the rat model has an 
elliptical area of 25.6 mm2, the one for the ultrasound normal incidence has a 
circular area of 19.64 mm2, while the one for the mouse model has the smallest 
elliptical area of 5.39 mm2. The size of collimators’ outlet was set to be no less 
than or at least commensurate with one ultrasound wavelength (i.e.  3 mm in soft 
tissue). One single-channel waveform generator (33220A, Keysight Technologies, 
Inc., USA) was working with another double-channel generator (33612A, Keysight 
Technologies, Inc., USA) to control the timing of each sonication, synchronize the 
ultrasound transmission with neural recording, and form the initial ultrasound 
waveform to be amplified, thus driving the transducer. A 50-watt wide-band radio-
frequency (RF) power amplifier (BBS0D3FHM, Empower RF Systems, Inc., USA) 
was employed to amplify the low-voltage ultrasound waveform signal. The 
employed ultrasound intensity levels and duty cycles are described in Table. 1. As 
noted in the table, all ultrasound conditions used the same UFF of 0.5 MHz, 
112 
 
ultrasound duration (UD, also known as sonication duration) of 67 ms, inter-
sonication interval (ISoI) of 2.5 s, tone-burst duration (TBD) of 200 μs. 
Table 2. Administered tFUS Conditions with Featured Parameters 
tFUS Conditions* UPRF (Hz) UDC (%) 
UPIx1 30 0.6 
UPIx10 300 6 
UPIx50 1,500 30 
UPIx100 3,000 60 
UPIx150 4,500 90 
* Except for the ultrasound pulse repetition frequency (UPRF) and ultrasound duty cycle (UDC), all 
the listed tFUS conditions use the same UFF, UD, ISoI, TBD, Isptp within each animal model. UPI 
stands for ultrasound pulsed intensity. 
5.2.3 Extracellular Recordings 
Extracellular recordings were made using 32-channel 10mm single shank 
electrodes, where electrode sites are arranged in 3 columns, spaced 50 microns 
apart from each other (A1x32-Poly3-10mm-50-177, NeuroNexus, Ann Arbor, MI, 
USA). Electrodes were inserted into the rodent skull using a small animal 
stereotaxic frame with 10-micron precision manipulators (Model 963, David Kopf 
Instruments, Tujunga, CA, USA). Electrodes were inserted at a 40-degree angle 




Rodents were sedated under either ketamine and xylazine cocktail or 
isoflurane. All animals were skin prepared with hair shaving and hair removal gel. 
Rodent heart rate, respiration rates and inter-rectal temperatures were monitored 
throughout recording. Cranial windows, 1-2 mm in diameter, are opened in the 
skull using a high-speed micro drill (Model 1474, David Kopf Instruments, Tujunga, 
CA, USA) under stereotaxic surgery assisted with microscope system (V-series 
otology microscope, JEDMED, St. Louis, MO, USA). Brain suture lines were used 
to identify brain structure locations. Recordings were obtained using the 
NeuroNexus Smartbox recording system (20 kHz sample frequency, 16-bit ADC, 
NeuroNexus, Ann Arbor, MI, USA).  All mentioned procedures on rodent models 
have been reviewed and approved by the Institutional Animal Care and Use 
Committee at University of Minnesota. 
5.2.4 Stimulation at Primary Somatosensory Cortex in Rats 
Rat subjects were adults in the weight range of 400 g to 600 g, sedated 
initially under ketamine and xylazine cocktail (75 mg/kg, 10 mg/kg) and extended 
with ketamine injections (75 mg/kg). This sedative approach allows us to achieve 
stable anesthesia with minimum body movement, e.g.  breathing, heat beating, etc. 
tFUS collimator is coupled with the rat skull using ultrasound gel. Ultrasound 
collimators are transmitted through intact skull, directed at 40 degrees angle 
towards the left S1 region on the rat head. 
5.2.5 Stimulation at Primary Somatosensory Cortex in Transgenic Mice 
Mice expressing ChR2(H134R) in select neuronal populations were 
achieved by crossing mice expressing ChR2 in a cre-dependent manner 
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(B6;129S-Gt(ROSA)26Sortm32.1(CAG-COP4*H134R/EYFP)Hze/J; Jackson labs 
stock number: 012569; also referred to as Ai32; donated to Jackson labs by 
Hongkui Zeng) with mice expressing Cre recombinase in either parvalbumin-
expressing cells, including fast-spiking inhibitory interneurons (B6;129P2-
Pvalbtm1(cre)Arbr/J; Jackson labs stock number: 008069 [208]; donated to 
Jackson labs by Silvia Arber; resulting cross referred to as PV-ChR2 in this 
manuscript) or in neurons expressing CaMKIIα, including RS excitatory cortical 
neurons (B6.Cg-Tg(Camk2a-cre)T29-1Stl/J; Jackson labs stock number: 
005359[209]; donated to Jackson labs by Susumu Tonegawa; resulting cross 
referred to as CamKII-ChR2 in this manuscript). Opsin-expressing offspring were 
identified by genotyping (for CamKII-ChR2 mice; Transnetyx) or via fluorescent 
protein visualization goggles (BLS, Budapest, Hungary) (for PV-ChR2 animals), as 
done previously [210]. 
Recordings were performed in adult mice, males and females, older than 8 
weeks old. Mice were sedated under isoflurane (4% during surgery, 2% during 
recording); Optoelectrodes (NeuroNexus, Ann Arbor, MI, USA) were inserted in 
the S1 (ML -1.5 mm, AP -1 mm, Depth 0.7 mm) at a 40-degree angle from the 
posterior, while tFUS was delivered at 30 degree incidence angle from the anterior 
in the same sagittal plane. After all tFUS recordings were performed, to avoid 
confounds of light delivery potentially altering neuronal firing properties, brief 
pulses of light (wavelength 465 nm, ≤ 10ms in duration, duration of light adjusted 
to avoid bursts of activity; PlexBright LED Module, Plexon, Dallas, TX, USA) were 
used to ‘optotag’ recorded neurons. Units which displayed an increase in firing rate 
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(defined as an increase above 99% confidence interval of spontaneous firing) 
within 10 ms of the light pulse were classified as excitatory neurons (in CamKII-
ChR2 mice) or parvalbumin-expressing inhibitory neurons (in PV-ChR2 mice). 
5.2.6 MUA Data Processing 
For spike analysis, neural traces were band-passed between 244 Hz and 6 
kHz, followed by Symlet wavelet denoising using Wavelet toolbox in MATLAB 
v9.0.0 (The MathWorks, Inc., Natick, MA, USA) to remove potential artifacts. All 
MUA spike sorting and single-unit preselection are performed using PCA based 
spike classification software Offline Sorter (Plexon, Dallas, TX, USA). Local field 
potentials (LFP) were band-passed from 1 Hz to 244 Hz, and denoised using 
Wiener filter and independent component analysis to generate Figure S3f. Further 
analyses, including the ISpI computation, PSTH, raster and return plots (also 
known as Poincaré plot, a second-order analysis method for nonlinear features in 
time series), feature extraction for the initial phase (IP) and afterhyperpolarization 
(AHP), descriptive statistics for spike waveform and spiking rates, LFP temporal 
and spectral analyses were performed using FieldTrip toolbox [211] in the 
MATLAB. After obtaining phase durations of IP and AHP, K-means clustering 
function in the MATLAB was employed to conduct the cluster analysis of neuron 
types. 
5.2.7 Ultrasound Pressure/Intensity Mapping 
In order to characterize tFUS stimulation’s temporal and spatial dynamics 
near our targets, we developed a three-dimensional ex-vivo pressure mapping 
system that uses a water submerged needle hydrophone (HNR500, Onda 
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Corporation, Sunnyvale, CA USA) driven by a 3-axial positioning stage (XSlide, 
Velmex, Inc., Bloomfield, NY, USA) to map out the spatial-temporal pressure 
profiles of ultrasound transmitted through an ex-vivo skull. The needle hydrophone 
was placed beneath an ex-vivo skull and recorded ultrasound pressure values at 
discrete locations (scanning resolution: 0.25 mm laterally, 0.5 mm axially) behind 
the skull.  Skulls were freshly dissected from euthanized animals. This setup allows 
us to quantify the amount of energy delivered to the brain, which varies 
substantially due to the inhomogeneity and aperture of the skull. The system can 
be set up to mimic the exact conditions of the ultrasound set up with matched 
collimator locations and angles. 
Based on the measured 3-D ultrasonic pressure map, the spatial-peak 
temporal-peak intensity (Isptp) is calculated using Equation 17 
𝐼                                                 (17) 
where 𝑃  is the maximal instantaneous pressure amplitude in both spatial and 
temporal domains, and 𝑍  is the characteristic acoustic impedance. This 
impedance can be computed using Equation 18 
𝑍 𝜌 ∙ 𝑐,                                   (18) 
where ρ is the medium density (1,028 kg/m3 for brain tissue, 1,975 kg/m3 for 
cortical bone[212]), and c is the speed of sound in the medium (1,515 m/s for brain 
tissue, 3476 m/s for cortical bone[212]). 
117 
 
We can also obtain the spatial-peak temporal-average intensity (Ispta) from 
temporal profile of ultrasound pressure at its spatial maximum, which is denoted 
as 𝑃 𝑡 . Equation 19 is used to calculate the Ispta. 
𝐼 𝑑𝑡 ∙ 𝑈𝑃𝑅𝐹                                     (19) 
5.2.8 Ultrasound Induced Temperature Rise 
As a safety concern, once obtaining the ultrasound pressure map, we did a 
numerical estimation of maximum temperature rise using the following calculation 
methods [213]. Firstly, we can obtain the Ispta from Equation 19, and then the rate 
of heat generation per volume is calculated using Equation 20. 
Q 2𝛼 ∙ 𝐼                               (20) 
Where α is the ultrasound amplitude absorption coefficient in brain tissue 
(0.03 Np/cm at 0.5 MHz [214]) or in cortical bone (3.45 dB/cm at 0.5 MHz [212]). 
Since we introduced the spatial-peak temporal-average intensity, the estimation of 
the Q value was maximized for the targeted site. Next, we borrowed the Equation 
21 from [215] to obtain the maximum temperature increase if we assume no heat 
removal process took place in the ultrasound energy deposition: 
∆T ∙∆                        (21) 
where ∆t is the tissue exposure time under tFUS, and C  is the heat capacity per 
unit volume (3.6 J/g/℃ for the brain tissue, 1.606 J/g/℃ for the skull [216]). We 
estimated the temperature rise at a disk-shape focal area with a radius of one 
ultrasound wavelength (i.e. 3 mm). With these, the estimation would produce an 
upper limit for the temperature change. 
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5.2.9 Statistical Methods 
The animal or neuron numbers reflect our past experiences in developing 
neurotechnologies. Non-parametric statistical tests were conducted in R v3.2.1. 
The neuronal spiking data normality and variance homogeneity were initially 
inspected with Shapiro-Wilk test and Fligner-Killeen test, respectively. All related 





Figure 37. In vivo experimental setup and recordings. (A) Collimator guiding focused ultrasound 
(US) to hair-removed scalp of an anesthetized rat model with an incidence angle of 40°, and a 32-
channel electrode array inserted at an incidence angle of 40° into the left primary somatosensory 
cortex (S1) prepared through a craniotomy. The rat head and brain model were 3D reconstructed 
from T2-weighted (T2W) MRI images [193]. (B) The spatial coordinates of electrophysiological 
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recordings. The coronal brain slice shows the location of electrode insertion as a physical breakage 
with the insertion depth of 1 mm at the left S1. A sagittal view of the Micro-CT image captured the 
surgical burr hole (approximate diameter: 2 mm) on the top of cranium. ML denotes the medial 
lateral distance from midline; AP denotes the anterior posterior distance from Bregma. (C) The 
temporal profile of tFUS. 100 cycles of sinusoidal wave formed a single ultrasound pulse, which 
generated a tone-burst at an ultrasound fundamental frequency (UFF) of 500 kHz for a tone burst 
duration (TBD) of 200 μs. Such ultrasound pulses were repeated at certain ultrasound pulse 
repetition frequency (UPRF) for a corresponding number within the ultrasound duration (UD) of 67 
ms. The inter-sonication interval (ISoI) was 2.5 seconds. (D to E) One transverse (X-Y plane) and 
one coronal (Y-Z plane) scans of ultrasound spatial-peak temporal-average intensity (Ispta) 
distribution under the cranium using a hydrophone-based US field mapping system. After 
transmission through an ex-vivo skull, spatial-peak ultrasound pressure is measured at 7.9 kPa, 
Ispta is 15.2 mW/cm2 at a UPRF of 1,500 Hz, and spatial-peak temporal-peak intensity (Isptp) is 405 
mW/cm2. (F) An example of acquired multi-unit activity (MUA) from the S1 using tFUS with 
UPRF=1500 Hz. The timing between the acoustic-induced action potentials and the administered 
stimulations are exemplified by 4 trials. The sham condition showed a silence of such MUA. (G) 
Typical examples of regular spiking unit (RSU) and fast spiking unit (FSU) separated from the 
recorded MUA. The waveform features, i.e. time durations of initial phase (IP) and 
afterhyperpolarization (AHP) were employed to conduct the units’ separation. 
5.3.1 tFUS Stimulation and Setup 
The in vivo experimental setup and the recorded neuronal action potentials 
are illustrated in Fig. 37. As presented (Fig. 37A), pulsed tFUS is first generated 
by a single-element transducer, guided to a scalp location over the left 
somatosensory cortex through a mounted 3-D printed collimator with an incidence 
angle of 40° [187]. Meanwhile a 32-channel electrode array is inserted using a 
stereotaxic arm into the targeted brain area (i.e. primary somatosensory cortex S1, 
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ML: -3 mm, AP: -0.84 mm, depth: 1 mm, Fig. 37b upper panel) prepared through 
craniotomy, and histologically confirmed through a coronal brain slice. The burr 
hole through the skull with an approximate diameter of 2 mm is shown in a sagittal 
CT image (Fig. 37B bottom panel). The stimulation dynamics of the tFUS 
waveforms consist of tone-burst sinusoidal waves with constant UFF (500 kHz), 
and TBD (200 μs), and varied UPRF, spanning five levels between 30 – 4,500 Hz 
(Fig. 37C, Table 2). The duration of inter-sonication interval (ISoI) is 2.5 seconds 
per trial. The spatial profile of the ultrasound in the x-y plane is superimposed on 
a rat cranium (Fig. 37D). A hydrophone-based 3-D scanning system was used to 
obtain measurements of the tFUS spatial temporal profile. The ultrasound spatial 
map from the coronal view (y-z plane) is reconstructed, in which mechanical 
energy distributed along a beam up to a depth of 4 mm, but spatial peak energy is 
located within a depth of 1 mm (Fig. 37E), i.e. the angled incidence[187] leads to 
a shallowed targeting at cortices. This ultrasound field pattern is resultant from a 
40-degree angled incidence, dissipating the majority of ultrasound energy through 
the skull. Angled tFUS stimulation is the preferred method for studying the cortex, 
as its activation pattern is shallower than orthogonal tFUS. As a result of the 
delivery of pulsed low-intensity ultrasound energy, increased firing rate is observed 
in recorded multi-unit activity (MUA, Fig. 37F). A sham US condition where the 
ultrasound transducer transmits ultrasound waves in air, directed 180 degrees 
away from the skull (Fig. 37D), is recorded to control for possible confounds due 
to acoustic and electromagnetic noise in the experimental setup. Stimulation 
performed at a secondary control site, during primary site intracranial recordings, 
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further demonstrated the spatial specificity of the ultrasound-induced brain 
activities (Figure 38). 
  
Figure 38. Spatial specificity of tFUS induced brain activations. (A) Another sham ultrasound
condition by relocating the incidence of tFUS at a posterior part of brain with ultrasound 
parameters as UPIx50. (B) Two EEG source imaging frames for tFUS (Figure 37A) and the sham
US conditions in (A) obtained from simultaneous 26-channel EEG recording. Local field potentials
(LFP) were compared. 
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5.3.2 Cell-type Specific Response to tFUS in Rats 
All recorded action potentials from our 32-channel electrode array were 
sorted based on the spike waveforms and inter-spike intervals (ISpI). Regular-
spiking (presumably excitatory) (RSU) and fast-spiking (presumably inhibitory) 
units (FSU) are thus identified based on the temporal dynamics of the action 
potential waveform [217-219]. The features extracted are the durations of initial 
phase (IP) of the action potential, i.e. from onset to the re-crossing of baseline, and 
afterhyperpolarization period (AHP), i.e. from the end of the IP to its re-crossing of 
baseline, demonstrated in Fig. 37G. These features have been associated with 
differences of ion channel distributions in the neuronal cell membrane. We thus 
hypothesize that the RSU and FSU will have distinct responses to various tFUS 
stimulation sequences, which is to be statistically tested given one of the putative 
mechanisms is that the mechano-sensitive ion channels mediate the acoustic 







Figure 39. Temporal dynamics of neuronal action potentials responding to administered 
ultrasound conditions. (A to F) The peri-stimulus time histograms (PSTH, bin size: 50 ms) and 
raster plots of the spiking unit (IP duration mean: 850 μs; AHP duration mean: 1850 μs, waveform 
depicted as an inset in (A)) responding to a tFUS condition (illustrated Fig. 1A) with UPRF of 1500 
Hz (A), and sham conditions used as a negative control (C) in which the ultrasound aperture was 
active but flipped away from the animal subject (SFLP, illustrated as Fig. 3D) and a positive control 
(E) in which the ultrasound was directed to an anterior part of the skull (SSKF, illustrated as Fig. 
3G). The histograms and return plots in (B to F) compared the differences of the first and second-
order statistics of inter-spike waiting time using a bin size of 0.1 ms. The color represents the 
number of spikes within the bin of certain inter-spike intervals. The insets within (D) and (F) show 
the return plots in their respective original scales. (G to I) The PSTHs of another spiking unit (IP 
duration mean: 700 μs; AHP duration mean: 600 μs, waveform depicted as an inset in (G)) recorded 
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from another rat in response to three tFUS conditions with UPRF of 300 Hz (G), 1500 Hz (H) and 
3000 Hz (I). All of the temporal dynamics are computed across 478 trials, with each trial lasting 2.5 
s. The applied ultrasound pulsed intensity (UPI) conditions are described in Table 1 (see Methods). 
Data are shown as the mean±95% confidence interval in the PSTHs. 
After recording the MUAs from the first group of wide-type male Wistar rats 
(N = 6), we studied the neural effects of the administered pulsed tFUS through 
intracranial recordings. Using the peri-stimulus time histogram (PSTH), we found 
a significant increase of spiking rate (18.24±2.03 spikes/sec, Fig. 39A) from one of 
the identified somatosensory cortical neurons (the inset of Fig. 39A, mean spike 
waveform IP: 0.85 ms, AHP: 1.8 ms) when stimulated with a tFUS condition (1500 
Hz UPRF, Ispta=15.2 mW/cm2). More intuitively, an increase of spiking as a function 
of time along 478 consecutive trials is demonstrated with the raster plot (Fig. 39B), 
in which the density of spiking events increases during the ultrasound stimulation. 
A significant bursting peak, a type of non-Poissonian, tFUS-mediated behavior 
showing in the return plot of ISpI (Fig. 39B). In the sham US conditions, no distinct 
spiking increase can be found in either the PSTHs, raster and return plots (Fig. 39, 
C to F). The pattern captured in the return plot of ISpI in the sham condition of 
SFLP demonstrates a type of exponential distribution of time between subsequent 
spikes, thus a Poisson distribution of the spike counts, which may indicate a well 
isolated, long refractory neuron (inset of Fig. 39D). When being further treated with 
the other sham condition of SSKF to potentially introduce another control for skull-
conduction, it can be seen from the PSTH (Fig. 39E) that the overall spiking rate 
of such identified single unit (inset of Fig. 39A) decreases comparing to Fig. 39A, 
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and the more dispersive pattern presented in the return plot at its original scale 
(inset of Fig. 39F) implies a more sporadic firing by this neuronal unit.  
In contrast, another identified cortical neuron (inset of Fig. 39G) with shorter 
durations of IP (mean: 0.7 ms) and AHP (mean: 0.65 ms) shows a more 
homogeneous PSTH distributions in response to three levels of tFUS treatments 
(Fig. 39, G to I) using the ultrasound setup shown in Fig. 37A. However, the firing 
rate (7.6±1.2 spikes/sec) is not altered significantly by the US stimulation (300 Hz 
UPRF, Ispta=3.0 mW/cm2) comparing to pre-stimulus rates (e.g. 7.5±1.2 spikes/sec 
at the bin of [-0.05, 0] s). Interestingly, for this neuron, we still found no significant 
changes in spiking rates (6.5±1.3 spikes/sec) even when ultrasound was 
administered at a UPRF 10 times higher (3000 Hz UPRF, Ispta = 30.4 mW/cm2, Fig. 
39I). From Fig. 39H, we can further observe that this fast-spiking unit (5.0±1.0 
spikes/sec) does not prefer the 1500 Hz UPRF (Ispta = 15.2 mW/cm2, Fig. 39H) 
when comparing to the unit in Fig. 39A. Overall, the baseline spiking rate variability 
of this fast-spiking unit may not be negligible across the three tFUS conditions, 
which might be due to the applying order of tFUS conditions, as in this case, the 
UPIx10 was applied prior to UPIx100 that was followed by the UPIx50. The time-





Figure 40. Cell-type selective responses to tFUS and sham US conditions. (A) k-means cluster 
analysis of 199 single units identified from 6 rats with blue solid circles depicting the RSUs while 
purple circles representing the FSUs. The majority is classified as the RSU with longer IP and/or 
AHP durations than the FSU. These spiking units are recorded and identified under the influence 
of the administered anesthesia (xylazine) and analgesic drugs (ketamine), in which the durations 
of both IP and AHP are observed to be longer than the results reported in literature [217, 220] for 
different sedative approaches. (B) The 146 RSUs significantly differ their responses to different 
tFUS conditions. Data are shown as the mean±s.e.m., with statistical comparisons made through 
Kruskal-Wallis one-way ANOVA and one-tail two-sample Wilcoxon tests with Bonferroni correction 
for multiple comparisons. (C) The FSU group, which consisted of fewer neurons (N = 53, marked 
as purple hollow circles), was observed to have a higher mean spiking rate than RSUs, whereas 
this FSU group showed no significant effect by different UPRF levels. Data are shown as the 
mean±s.e.m., statistics by Kruskal-Wallis one-way ANOVA. (D) The experimental setup of the 
sham US condition as a negative control (SFLP). The ultrasound transducer was flipped its aperture 
by 180°, although the pulsed ultrasound and the intracranial recordings were maintained. (E) The 
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cluster analysis for another 108 single units identified from the sham US condition. 80 RSUs and 
28 FSUs were separated. (F) RSUs showed a homogeneous lack of response to sham ultrasound 
conditions. No significant effect by the ultrasound conditions was observed through statistics by 
Kruskal-Wallis one-way ANOVA. Data are shown as the mean±s.e.m. (G) The experimental setup 
of the sham US condition as a control for bone-conduction (SSKF). The ultrasound incidence took 
place at an anterior location of the skull, and the aperture was kept transmitting ultrasound. (H) The 
third cluster analysis for another 127 single units identified from the sham condition of SSKF. 89 
RSUs and 38 FSUs were separated. (I) RSUs also showed a homogeneous lack of response to 
the SSKF sham ultrasound conditions. No significant effect by the ultrasound conditions was 
observed through statistics by Kruskal-Wallis one-way ANOVA. *p < 0.005, **p < 0.001. NS, not 
significant. s.e.m., standard error of mean. 
Given these case studies, we pursued a statistical investigation of the 
behavior of different neuron types in response to tFUS and sham conditions, 
across multiple levels of UPRFs. In the tFUS group, we compiled all single unit 
activities during the UD of 67 ms recorded from the rats, and separated them into 
RSUs and FSUs using k-means cluster analysis (Fig. 40A). 199 identified single 
units were separated into the two groups, with the RSU group containing 146 units. 
The sample sizes are unbalanced due to the prevalence of each cell types in the 
cortex. In the RSU group, we found a statistically significant effect by the UPRF 
levels (Kruskal-Wallis chi-squared =14.45, p = 0.006), which indicated that the 
RSUs change their spiking rates accordingly in response to the tFUS conditions 
(Fig. 40B). More specifically, the spiking rates have shown an increasing trend 
along with the elevating UPRFs.  
Furthermore, we found 2 significantly different pairs among 10 two-sample 
post-hoc tests (Fig. 40B, thresholding at p < 0.005 Bonferroni corrected for multiple 
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comparisons), in which our null hypothesis was that the RSUs’ spiking rate in the 
low UPRF ultrasound condition would be no less than the one in the high UPRF. 
As a result, the spiking rates in UPIx50 was not significantly higher than those in 
the other two low UPRF conditions (p > 0.1). In the FSU group (Fig. 40C), no 
significant difference between tFUS conditions could be found (Kruskal-Wallis chi-
squared = 4.34, p > 0.3). This implies that the spiking rates of the FSUs were not 
significantly altered by the levels of UPRF, consistent with our case study (Fig. 39, 
G to I). The contrast between the responses observed in these two different neuron 
types suggested a cell-type selective mechanism by tFUS. Unsurprisingly, the 
RSU group did not show significant differences among the five levels of sham US 
conditions, including the SFLP sham (Kruskal-Wallis chi-squared = 5.94, p > 0.2, 
Fig. 40F) and the SSKF sham (Kruskal-Wallis chi-squared = 0.96, p > 0.9, Fig. 40I). 
Through these results, we demonstrate that in an anesthetized rat model, the 
RSUs significantly increase their firing rate in response to UPRF as high as 4500 
Hz, although the median value of the rate at 1500 Hz and 3000 Hz UPRFs became 
higher than the value in its corresponding sham condition (UPIx1500 tFUS vs. 
SFLP sham: 4.11±0.77 vs. 3.62±0.84; UPIx3000 tFUS vs. SFLP sham: 4.53±0.72 
vs. 2.09±0.50). In spite of the none dependency on the UPRFs, we notice that the 
UPIx1 SSKF sham, however, demonstrates a high spiking rate (UPIx1 tFUS vs. 
SSKF sham: 2.06±0.41 vs. 6.21±0.78), this is possibly due to the more effective 
sensory input induced by the low UPRF (30 Hz) ultrasound targeting at the anterior 
scalp close to the sensory hairs. 
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The distinct difference in responses of RSUs and FSUs to the change of 
ultrasound UPRF has not been reported in literature. Although it is not surprising 
to see that the FSU spikes faster than the RSU does, since the length of the 
refractory period determines the minimum time between neuronal firings. The 
spiking rate contrast between these two groups can be observed in Fig. 40, B and 
C. When administered with a low UPRF (such as 30 and 300 Hz), the RSUs do 
not respond to tFUS stimulation, while FSUs maintain a stable spiking state during 
the sonication. The observed responses suggest cortical neurons with different 
action potential shapes, hence different distribution of ion channels in terms of ion 
channel types or relative quantity, have a distinct response patterns to tFUS UPRF. 
While FSUs are excited across all UPRF frequencies, RSUs only exhibit increased 
firing rate during high UPRFs. This could explain why when stimulating at low 
UPRFs, some previously reported studies have observed tFUS suppression 
effects [97, 138]. The observed effects may not simply be due to the lack of 





Figure 41. Validation of UPRF preferences by inhibitory and excitatory neurons. (A) A mouse-
specific 3D printed collimator guiding tFUS to hair-removed scalp of an anesthetized (2% 
isoflurane, 2 mg/kg bupivacaine subcutaneously) transgenic mouse model with an incidence angle 
of 30°, and a 32-channel optoelectrode array inserted at another incidence angle of 40° into the left 
S1 prepared through a craniotomy. The blue light stimuli were pulsed using a PlexBright LD-1 
Single Channel LED driver at 30 mA, and were then delivered via optical fiber (105 μm diameter) 
to the recoding side of the shank. (B) The PSTHs (bin size: 50 ms) of the PV spiking unit (IP 
duration mean: 550 μs; AHP duration mean: 850 μs) and the CAMKIIa spiking unit (IP duration 
mean: 600 μs; AHP duration mean: 1100 μs) responding to the optical stimuli. Spike waveforms 
depicted as insets in (b), solid red line as the mean waveform, dashed lines as the waveform 
standard deviation. Data are shown in the PSTHs as the mean ± 95% confidence interval. (C) 
Comparing PV and CamKIIa neurons regarding the IP and AHP phase durations. Data are shown 
as the mean±s.e.m., statistics by two-tail Wilcoxon test. (D to E) The spiking rates comparison 
between treatment conditions of UPIx1 and UPIx10 within PV and CAM neurons respectively. Data 
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are shown as the mean±s.e.m., statistics by two-tail Wilcoxon test. *p < 0.05, **p < 0.01, ***p < 
0.001. 
5.3.3 Optogenetics Confirms Cell Type Specific Response in Mice  
To access our cell-type specificity hypothesis, we tested our results in 
transgenic mouse model with PV (N = 52, from 3 mice) and CamKIIa (N = 42, from 
2 mice) cortical neurons confirmed by responding to optical stimulations. Fig. 41A 
illustrates the in vivo experimental setup combining the optical stimulation, tFUS 
and multi-channel intracranial electrophysiological recordings. The optogenetic 
stimulation (wavelength = 465 nm) locally activates a subpopulation of 
channelrhodpsin expressing neurons, based on the MUA recording from our 
optoelectrode we can thus identify the cell type of our recording neurons (Fig. 41B). 
The waveforms of action potentials of each neuron are illustrated together with the 
spiking rates when receiving the optical stimuli (Fig. 41B). Since the activation of 
channelrhodopsin has been linked to changes in neuronal baseline spiking 
dynamics, all optogenetic stimulations are administrated after completing all tFUS 
recording sessions. 
In changing animal models from rats to mice, we changed the outlet size of 
our collimator for the small mouse brain (see Methods for a different outlet size) 
but we maintained the same tFUS transmission parameters. We were not able to 
replicate the higher tFUS UPRFs at the same intensities since the mouse skull 
provides much lower attenuation than the rat skull whereas our stimulation 
parameters are designed for stimulations on rats. At high UPRFs we observed 
significant noise in our recordings. Between PV and CamKIIa neurons, we 
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observed significant differences in the action potential waveforms regarding the IP 
and AHP phase durations, validating our method for separating neuron population 
in rats (Fig. 41C, p < 0.001). In PV neurons, spike rates are higher under tFUS 
stimulation at UPRF of 30 Hz (Fig. 41D, p < 0.001), while in CamkIIa neurons, 
significantly higher spike rates are observed during tFUS stimulation at UPRF of 
300 Hz (Fig. 41E, p < 0.05). The difference in response to tFUS UPRFs across 
these two neuron types shows further evidence of cell-type specific effects of tFUS. 
Caution should be taken when directly comparing the mice and rats subject 
groups due to the difference in animal models and anesthesia methods. These 
results indicate that different animal models may have significantly different 
responses to ultrasound UPRFs. For example, the differences of both excitatory 
(CamKIIa) and inhibitory (PV) neurons in response to the 30 and 300 Hz UPRFs 
are significantly contrasted (Fig. 41, D and E) comparing to the observations from 
non-transgenic rats (Fig. 31, B and C). However, the cell-type specific response 
profile to different ultrasound UPRFs are conserved across the two animal models 
studied. 
5.4 Discussion 
In the present study, we set out to use multichannel intracranial recordings 
to test our hypotheses of tFUS’s ability to induce cell-type specific stimulation. 
Based on the results reported above, we have gained more understanding of the 
tFUS parameter space, and can furthermore infer on the mechanism of action of 
tFUS stimulation. Besides macroscopic perspectives reported in literature, 
uncovering the underlying mechanism requires a detailed inspection of how 
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neurons respond to a vast set of acoustic parameters. Recordings using multi-
channel intracranial electrophysiology allows us to examine the neuron cellular 
dynamics with high spatial and temporal specificity. 
5.4.1 An Intrinsic Selectivity between Excitatory or Inhibitory Neurons by tFUS 
UPRF 
The results reported above are in vivo evidences that subsets of neurons, 
grouped by their action potential waveforms, respond differently to tFUS 
stimulation UPRFs. This provides insight into results previously reported by other 
groups studying tFUS [97, 113, 129, 187]. Our results suggest that tFUS interacts 
with neurons based on ion channel dynamics. Hence, the intrinsic differences in 
ion channel dynamics between different neuron types contribute to differences in 
the neuron’s response to tFUS. 
The ultimate goal of studying the mechanisms of tFUS is to translate the 
technology to clinical utility. Previous studies have shown that inhibitory effect of 
tFUS was found at the primary somatosensory cortex [97] and thalamus [138] in 
humans, in which the same ultrasound parameters were employed (single-element 
transducer with UFF = 500 kHz, UPRF= 1 kHz, UD = 500 ms, UDC = 36%). In 
contrast, other studies on humans have shown excitatory effects that the primary 
visual cortex was directly excited with a specific ultrasound administration (UFF = 
270 kHz, UPRF = 0.5 kHz, UD = 300 ms, UDC = 50%) [113], and simultaneous 
stimulating capability of tFUS were also shown at primary and secondary 
somatosensory cortices (UFF = 210 kHz, UD = 500 ms) [142]. 
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Given these parameter-dependent studies, the effects of tFUS achieved by 
these two groups are sometimes observed to be inconsistent or even contradictory 
on healthy, awake subjects. We cannot conclude from these studies whether the 
observed behavior was due to overall activation or suppression of neural activity 
due to changes in tFUS parameters, or if the ultimate behavior was due to selective 
modulation of the neural network. The modified NICE model was proposed to unify 
the ultrasound parametric space and predict either excitatory or inhibitory effects 
at a neuronal level [203]. As we set out to explore the tFUS parameter space in 
the in vivo brains, we set our administered duty cycle of tFUS to the five levels (see 
Table 2) while maintaining the Isptp as a constant. When tuning tFUS parameters, 
we discovered that neuronal units grouped based on spike shape characteristics 
display different spike rate during the same tFUS stimulation. The excitatory 
neurons (RSUs) exhibit higher spiking rates when stimulated with high UPRF, thus 
high duty cycle, whereas the inhibitory neurons (FSUs) exhibit high spiking rate 
during stimulation at all UPRFs studied. The inhibitory phenomena found by Legon 
et al. [97, 138] resulted from a UDC located in a transition zone between tFUS 
induction of inhibitory and excitatory effects [203], whereas the brain activation 
reported by Lee et al. [113, 142] is probably due to the applied higher UDC. In 
other words, the UDC of 50% has already significantly increased the activity of 
excitatory neurons, and since the spiking activity of the inhibitory neurons does not 
increase proportionally, resulting in facilitation of behavioral outcomes. 
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5.4.2 UPRF: Possible Mechanism of Cell-type Specific Effects 
In a recent study, acoustic radiation force (ARF) has been inferred as the 
most probable energy form that induces UPRF-dependent behavioral responses 
[133]. In the present study, when different UPRFs are used to stimulate cortical 
neurons, we observed a significant difference in response between two neuron 
subpopulations. We also believe that the difference in response between different 
neuron types is observed due to the interactions between transcranial ARF and 
ion channels in the neuron membrane. Neurons exhibit different action potential 
waveforms due to the difference in distribution of membrane proteins both in 
channel types and relative quantity of each type of ion channel. These distinct 
types of membrane proteins may have different response dynamics to acoustic 
radiation force [199, 221]. The basis of our hypothesis was demonstrated between 
the FSUs and RSUs in rat S1 cortex.  
We further tested this hypothesis in the S1 cortex of transgenic mice. 
Optogenetics is used to identify excitatory neuron and inhibitory neuron 
populations, by coexpressing channelrhodopsin only in CamKIIa and PV 
expressing neurons. Although we cannot verify whether FSUs and RSUs 
correspond directly to PV neurons and CamKIIa neurons in this study, this model 
allows us to study specific protein expression to neuronal responses to tFUS 
stimulation.   
In this model, we also observed a distinct spiking response to tFUS 
stimulation UPRFs. Thus, in two different in vivo models, and two different methods 
to identify cell types, we have observed distinct responses to tFUS stimulation 
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UPRFs. Based on our findings, future investigations can use genetic approaches 
to attribute the observed cell-type specific response to differences in protein 
expressions in different neuronal types. 
5.4.3 Ultrasound Safety 
All ultrasound parameters employed for targeting at the cortical region used 
on the S1 cortex of rats are maintained with Ispta below 50 mW/cm2, which lead to 
negligible temperature rises (< 0.001 ℃) at the targeted brain area. In addition, the 
mechanical index (MI) used in these experiments is less than 0.1, given the low 
peak negative pressure (i.e. < 100 kPa). Such low MI makes cavitation in brain 
tissue unlikely. These levels are well within the levels advised by the Food and 
Drug Administration (FDA) standard for ultrasound diagnostic imaging safety [189, 
222]. Hematoxylin and eosin stains gathered immediately after stimulation in both 
S1 and the hippocampus show no evidence of neuronal damage, local 
hemorrhage or inflammatory response at the stimulation site. 
5.4.4 Controls for Confounding Effects 
Based on a simultaneous EEG source imaging technique applied on rats 
reported previously [83], observations of the auditory cortex can be induced as a 
secondary activation when tFUS is not directed at the auditory cortex (see Figure 
S3a). Therefore, in order to examine the auditory side effects of our tFUS setup, 
presumably due to tFUS induced mechanical vibrations transmitted through the 
skull, we conducted tFUS stimulation in rats after chemical deafening (Fig. 42). 
Our observations of a local rise in local field potential (LFP) at the S1 cortical region 
in both control subjects and subjects with significant reduction in hearing (see Fig. 
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42d-e), suggest that side-effect activations in the auditory cortex from tFUS 
induced hearing percepts do not dictate activation of S1 cortex. Surprising, in this 
deafened model, the tFUS-induced LFP resembles the reported LFP waveform by 
Tufail, et al. [112]. Similar ultrasound parameters (e.g. UFF and UPRF) were 
employed in both studies. Although the chemicals used in this group of 
experiments have been shown to damage auditory pathways, we do not have 
confirmation of whether these drugs present toxicity to other parts of the neural 
network. Therefore, one should be cautious in critically evaluating recordings 




Figure 42. tFUS induced local brain activity on a chemical-induced deafened rat. (A) On a 
healthy wild-type rat, using EEG-based source imaging technique for tFUS, the administered 
ultrasound (UPIx50) activated a targeted brain area with a 40-degree ultrasound incidence angle. 
Besides, we can also notice the bilateral activation at auditory cortical regions. We initially reported 
this finding at the 3rd Annual BRAIN Initiative® Investigators Meeting. (B) The experimental protocol 
for creating chemical-induced deafening model. The deafening will be tested by pre- and post-
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chemical injection ABR tests on Day 0 and Day 3, respectively. A combination of injected chemicals 
includes furosemide and gentamicin. (C) The ABR test using speaker as sound stimulation source. 
Gold-cup electrodes are used to measure the brainstem response induced by the tone-burst sound. 
The rat subject is anesthetized using 2% isoflurane through inhalation. (D) ABR test results before 
chemical injection. Four levels of sound intensity with 16 and 24 kHz center frequencies were used. 
(E) On Day 3, post-injection ABR test results show significantly reduced auditory brainstem 
responses at three center frequencies (8, 16, 24 kHz) with each applying four levels of sound 
intensities. (F) LFP recorded at the S1 area and averaged across 478 trials. The employed 
ultrasound condition is UPIx50. Comparing with a sham condition (SSKF: relocate ultrasound 
incidence to a site anterior to the S1 as shown in the inset). The green circle in the inset shows the 
sham ultrasound incidence location, while the red circle indicates the location targeted in the tFUS 
condition. In this deafened rat model, the tFUS-induced LFP still resembles the reported waveform 
by Tufail, et al. [112]. Similar ultrasound parameters (e.g. UFF and UPRF) were employed in their 
work. (G) The time-frequency representations at multiple frequency bands illustrate the differences 
between tFUS and SSKF conditions. 
Since our stimulation location is at the primary somatosensory cortex, 
control studies were conducted to examine whether activations recorded in the S1 
could be due to somatosensation rather than direct activation of neurons in the S1. 
In a study examining the effect of tFUS on anesthesia recovery time, naïve male 
rats around 12 weeks (body weight: median 386 g, range 370 – 400 g) were 
injected only with an initial dose of ketamine and xylazine cocktail (75, 10 mg/kg 
respectively) adjusted according to the animal weight. After sedation, rats are skin 
prepared and kept on heat pads to allow for recovery from anesthesia. 
Temperature, heart rate and video recording of movements are monitored. 
Recovery time is defined based on injection time and time of first perceived 
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movement. Rats are divided in 3 subgroups. Group 1 (N = 6, Fig. 43A) received 
tFUS stimulation (UPIx50) at S1HL, peripheral stimulation electrodes are set at the 
contralateral hindlimb with no current injection. Group 2 (N = 3, Fig. 43C) received 
sham ultrasound directed 180 degrees away from the skull (Fig. 40D), only a 
collimator filled with ultrasound gel above S1HL, and peripheral stimulation 
electrodes are set at the contralateral hindlimb and monopolar pulse of peripheral 
stimulation at the contralateral hindlimb, current thresholds set at minimum current 
(1-3 mA dependent on subject, 0.08 – 0.1 ms set by PowerLab 26T) to induce a 
visible muscle contraction. Group 3 (N = 3, Fig. 43B) received tFUS directed at the 
anterior part of the skull away from cortical regions of the brain (shown as the inset 
of Fig. 42F), and peripheral stimulation electrodes were set at the contralateral 
hindlimb with no current injection. We combined the Groups 2 and 3 as a Sham 
US group, and compared this new group to the Group 1. As a result, rats with tFUS 
stimulation directly at S1 (UPRF = 1500 Hz) recovered from anesthesia 
significantly faster than rats during Sham US. Controls were tested for rats for 
auditory percepts coupled and not coupled to the skull, and rats with peripheral 
stimulation at the contralateral hind limb to control for somatosensation. Control 
rats with auditory percepts coupled to the skull has tFUS focused on the skull, far 
away from S1, control rats with auditory percepts not coupled to the skull have 
ultrasound directed 180 degrees away from S1. This study suggests that our tFUS 
experimental setup can elicit direct stimulation of the rat brain without confounding 




Figure 43. tFUS treatment leads to reduced anesthesia duration. (A to C) Experimental setups 
for administering tFUS (A), SSKF (B), and peripheral electrical stimulation (C). Two cameras do 
the videotaping after the anesthesia injection until an animal subject restores its moving capability. 
(D) One-tail Wilcoxon test for a comparison between Sham US (i.e. SSKF and electrical stimulation 
at contralateral hindlimb only) and tFUS. Data are shown as mean ± s.e.m. *p < 0.05. 
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5.4.5 Study Limitation 
In this work, the rodent models were sedated by anesthetic agents, which 
may introduce an inevitable confounding factor of changing the neuronal spiking 
activities. In particular, the injection of ketamine/xylazine does not provide a 
constant anesthesia level. However, we have tried to randomize the order of 
applied tFUS and Sham US conditions, which helps reduce the influence of 
anesthetic level to the statistical analyses. Based on literature reported first-order 
drug elimination kinetics, we established a numerical model to estimate the 
ketamine/xylazine blood concentration. When the anesthetic agents and 
ultrasound conditions were considered as factors, and the spiking rates during the 
sonication were considered as responses, a simple ANOVA test indicates no 
significant effect in comparisons among ultrasound conditions by using the 
anesthetic agents (data not shown). 
Caution should be taken when comparing between mice and rat models 
under tFUS stimulation. Our major constraint was due to the lack of widely 
available, well studied transgenic rat models for optogenetic stimulation. The 
thickness of the mice skull over the S1 cortex is 5 to 10 times thinner than that of 
rats. This leads to different distortions in tFUS field which may result in differences 
during stimulation. For mice subjects, a different collimator with a smaller tip size 
was used (see 5.2.2) to account for a smaller S1 region in order to avoid stimulating 
a widespread area in the mouse cortex. Discrepancies in activation area may also 
contribute to confounding results. Furthermore, rats were anesthetized with 
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ketamine and xylazine cocktails while mice were anesthetized with isoflurane due 
to differences in experimental setup. Such a difference in anesthesia methods 
could also contribute to differences in results. 
Regarding the effective harnessing of ultrasound energy, besides restricting 
the size of collimator outlet to be commensurate with the ultrasound wavelength, 
we are also cautious about the potential effect of using the 2-mm burr hole (Fig. 
37B) via which the electrode array is able to reach the neurons. For this reason, 
we have introduced the 3D ultrasound field mappings (Fig. 37, D and E) to explore 
potential alterations because of the low-acoustic-impedance conduit. And due to 
the requirement of 3D scanning of ultrasound field, we were only able to place the 
needle hydrophone (50 mm length) behind a freshly excised skull top piece in 
water, rather than inside a hollow rodent skull and conducted the ultrasound 
pressure mapping. However, the latter one is believed to be more demanded so 
as to obtain additional knowledge of how significant of standing waves would be 
inside the rodent skull cavity by using the 500 kHz UFF, given that considerable 
interference patterns due to standing waves has been reported by administering 
320 kHz tFUS to rats [223].  
Furthermore, the angles of the ultrasound incidence are designed to 
physically accommodate the ultrasound apparatus and the recording probe, in 
which we tried to preserve the ultrasound wave in the longitudinal mode versus the 
shear mode. Although it is unavoidable in the practice, the angled tFUS may 
introduce nontrivial shear wave propagating along the skull, and thus lead to 
increased skull conduction. Nevertheless, the difference in the ultrasound wave 
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Chapter 6. Summary and Outlooks 
6.1 Summary 
6.1.1 High-frequency Magnetoacoustic Tomography with Magnetic Induction 
(hfMAT-MI) [146] 
We have developed a hfMAT-MI imaging system which provides electrical-
conductivity imaging with a 1-mm spatial resolution, a significant improvement over 
conventional MAT-MI methods. We have also conducted pilot studies on in vivo 
tumor-bearing mouse models. Our results demonstrate the capability of hfMAT-MI 
for better discriminating transplanted human cancer tissue from normal 
surrounding tissues with internal details. To the best of our knowledge, this is the 
first in-vivo study using hfMAT-MI to track the tumor growth and establishes the 
feasibility of applying this magneto-acoustic imaging for early breast cancer 
detection. 
6.1.2 Contrast-enhanced Magnetoacoustic Imaging with Magnetic Nanoparticles 
[47] 
We demonstrated the capability of the MAT method to detect and 
reconstruct the distribution of superparamagnetic iron oxide nanoparticles 
embedded in-vivo within live, nude mice containing induced LNCap prostate 
tumors. As this is an ultrasound based imaging method using a short pulsed 
magnetic field, the present method has good resolution and imaging depth for 
potential applications in imaging tumors within soft tissue. 
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6.1.3 Non-Invasive Brain Imaging Perturbed by Low-intensity tFUS [83] 
In this study, we have demonstrated, in an in vivo experiment in three rat 
subjects, that low-intensity tFUS (e.g., Ispta < 1 mW/cm2) can induce brain electrical 
activity in the target region of tFUS. We have noninvasively recorded multichannel 
scalp EEG following low-intensity tFUS and have localized and imaged tFUS-
induced brain activation from scalp recorded EEG distributions. Our promising 
results demonstrate the feasibility of noninvasive sensing low-intensity tFUS-
induced brain activation and localization and imaging of brain activity from 
noninvasive scalp EEG signals. This study suggests that the proposed 
perturbation-based neuroimaging using tFUS-ESI merits further investigation and 
may become a useful tool for delineating normal and pathological brain networks 
and circuitry in a well-controlled and noninvasive manner. The ESI-guided tFUS 
may also have important applications to the treatment and management of various 
brain disorders. 
6.1.4 Towards the Mechanism of Ultrasound Neuromodulation with Intracranial 
Electrophysiological Recordings 
Transcranial focused ultrasound (tFUS) is a promising neuromodulation 
technique, but its mechanisms remain unclear. We investigate the effect of tFUS 
stimulation on different cell types and synaptic connectivity in in vivo anesthetized 
rodent brains. Single units were separated into regular-spiking and fast-spiking 
units based on their extracellular spike shapes, further validated in transgenic 
optogenetic mice models of light-excitable excitatory and inhibitory neurons. We 
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show that excitatory neurons are significantly less responsive to low ultrasound 
pulse repetition frequencies (UPRFs), whereas the spiking rates of inhibitory 
neurons do not change significantly across all UPRF levels. Our results suggest 
we can preferentially target specific neuron types noninvasively by altering the 
tFUS UPRF. 
6.2 Outlooks 
6.2.1 Combining the Diagnostics and Therapy Using the Nanoparticle-mediated 
Magnetoacoustics. 
Mapping the biological tissues’ electrical conductivity, the (hf)MAT-MI has 
been developed to pursue a potential clinical use in cancer diagnosis with an 
ultrasound spatial resolution. The contrast-enhanced MAT using MNPs further 
shows the capabilities of non-invasively estimating the bio-distribution of MNPs, 
especially the tumor-targeting nanoparticles. Along with the rapid developing bio-
material science, we can anticipate more effective tumor-targeting MNPs with 
improve retention rates. Thanks to the wide MNP imaging dynamic range of the 
MAT, a theranostic use by combing the targeted therapy with diagnosis may further 
lead more beneficial applications. Fig. 44 summarizes imaging modalities and 
applications for MNPs. 
Magnetic resonance imaging was firstly used to image magnetic 
nanoparticle-labeled molecular targets, as it is able to provide an enhanced image 
contrast because of its nature that can significantly shorten relaxation time [224]. 
Research is ongoing to reliably detect such signal changes at concentration levels 
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in the 1- 10 mg Fe/mL range. With the sweep imaging with Fourier transformation 
(SWIFT) MRI technique, quantitative imaging of up to 3 mg Fe/mL concentration 
of MNPs is possible.  
X-ray CT scanning has also been explored as another approach for 
estimating the distribution of magnetic nanoparticles [225]. It is seen that the MNP 
distribution above 10 mg Fe/mL is well recognized in the CT images with the 
sensitivity being limited below this concentration. Unfortunately, the cost of MRI or 
CT imaging systems may prove prohibitive towards large scale screening for early 
cancer detection applications. Ultrasound based system, like pulsed magneto-
motive ultrasound (pMMUS) imaging [226] and MAT [47] may provide cost-
effective imaging alternatives. 
Magnetic Particle Imaging (MPI) is a tomographic imaging method taking 
advantage of using the nonlinear response of magnetic nanoparticles to an 
external magnetic field [227]. Magnetorelaxometry is based on the magnetisation 
of MNP in a magnetic field and the detection of their relaxing magnetisation 
following the switch-off the magnetic field [228]. Both approaches have high 
sensitivity, thus a much low detection limit. However, to further incorporate more 
biomedical applications in which relative high MNP concentrations are required, 
the MAT is potentially to cover more applications including cancer therapies, e.g. 
hyperthermia therapy, drug delivery and further release. 
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6.2.2 Simultaneous Scalp EEG and Intracranial Recordings for A Multi-scale 
Perspective of Ultrasound Neuromodulation. 
 A natural setting is more preferred than e.g. the fMRI for better 
understanding the ultrasound-brain interaction, and promoting to uncover the 
mechanism of ultrasound neuromodulation. Although the fMRI is featured with high 
spatial resolution, the required strong static magnetic field per se may alter the 
excitability of neural circuits [114], and the pulsed magnetic imaging sequence may 
also lead to inevitable auditory responses. With a much better temporal resolution, 
I have been devoted to use the electrophysiological recordings, e.g. scalp EEG 
Figure 44. Application vs. imaging modalities for MNPs. MPI: magnetic particle imaging. MRI:
magnetic resonance imaging. MAT: magnetoacoustic imaging. (Presented in 4th Global Conference 
on NanoEngineering for Medicine & Biology, Minneapolis, USA, 2015) (Courtesy of Dr. Qi Shao) 
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and intracranial electrode array to investigate the ultrasound-mediated brain 
activities. Combining global and local pictures of the brain responses are of high 
importance; therefore, a simultaneous multi-scale electrophysiological recording 
and interpretation framework, e.g. correlation of EEG and LFP waves and their 
coherence in varies bands, hold a great promise in the neuroscientific research of 
tFUS. With further efforts on closed-loop control of ultrasound parameters based 
on the real-time monitoring of brain responses, effective paradigms are hoped to 
be identified (Fig. 45). Overall, by successfully developing this simultaneous multi-
scale technique along with the advancement of ultrasound technologies, tFUS is 
believed to become an effective, and widely-used brain stimulation approach. 
Figure 45. Simultaneous multi-scale electrophysiological recordings with closed-loop
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